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Summary
Nature has designed proteins to fold to specific three-dimensional structures
and to function as structural chemical building blocks in living systems.
The sequence of amino acids encodes the native structure as well the energy
landscape in which the protein searches out conformations. The functional
native state of the protein most often corresponds to the thermodynamic
free-energy minimum conformation at physiological conditions. The dis-
covery of protein aggregation diseases, however, where multiple proteins
sacrifice contacts in the globular state in favor of inter-chain contacts with
neighboring proteins, suggests that some proteins have aggregated states
that are thermodynamically equal if not more favorable than the native
state. Many of these aggregates have a common morphology known as an
amyloid fibril. Amyloid fibrils are composed of an intramolecular β-sheet
core running perpendicular to the fibril for some micrometers in length and
a few nanometers in diameter. There at least 16 distinct human diseases
that are associated with amyloid fibril formation. Although early attention
focused on the possible toxicity of the amyloid fibrils, it is now accepted
that the prefibrillar intermediates are the main toxic species in aggregates.
It has also been found that under a variety of solution conditions, most
proteins can form amyloid fibrils indistinguishable from those of the amy-
loid diseases. Because of the difficulties in obtaining detailed structural
information by X-ray crystallography or solution phase NMR spectroscopy,
computational approaches are needed to identify physicochemical properties
of sequences involved in the β-aggregation.
In Chapter 2, aggregation properties of small peptides are investigated
by using a genetic algorithm optimization in sequence space and molecular
dynamics sampling of conformation space. As target structures for the op-
timizations we used the parallel and the antiparallel β-sheet conformations
of three heptapeptides: 1632 different sequences were sampled, for a total
amount of 81µs of simulation. We found that in sequences selected for par-
allel aggregation the number of aliphatic and aromatic residues increases
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almost monotonically, while the number of charged and polar residues de-
creases. The opposite is observed in sequences selected for antiparallel aggre-
gation. Results of the genetic algorithm optimization represent an essential
element in the derivation of the equations presented in Chapter 3 and 4.
In Chapter 3, we report a formula to predict the change of aggregation
and disaggregation rate upon amino acid mutation. In the derivation of the
model, we used simple physicochemical properties of amino acids, such as the
polar and apolar water-accessible surface areas, the pi-stacking interaction of
aromatic residues, the dipole moment, the β-propensity, and the charge. To
have the most general model possible, we did not use any parameters that
need to be estimated from experiments. Although the application of the
equation shows high correlation with experimental data, the model require
the a priori knowledge of wild-type aggregation rates.
In Chapter 4, we report an equation that does need any information apart
from the amino acid sequence and two environmental factors (i.e., temper-
ature and concentration) to compute the aggregation rate. Our model was
used to predict the aggregation rates of human muscle acylphosphatase, islet
amyloid, α-synuclein, tau, glucagon, calcitonin, fibronectin, titin, and toll
with a correlation of 95%. Moreover, the equation allows the calculation
of the amyloid spectrum of a protein, identifying those segments which are
involved in the β-aggregation. In addition, the model distinguishes between
the parallel and antiparallel β-sheet organization within the fibrils and shows
that mammalian and non-mammalian prion proteins have different amyloid-
spectra.
In Chapter 5, we analyze complete proteomes of several eukaryotes to
identify changes of β-aggregation propensity through organisms of different
complexity. From P. tetraurelia to H. sapiens, we found that proteomes of
multicellular and more long-lived eukaryotes contain fewer sequences with
high β-aggregation propensity and more proteins with low β-aggregation
propensity. We also observed that compared to random proteomes, natural
proteomes are enriched in proteins with low β-aggregation potential as well
as proteins with high β-aggregation potential. Such polarization indicates
the dual evolutive requirement of intrinsically disordered proteins with low
β-aggregation propensity as well as proteins with a stable fold which comes
at the cost of higher β-aggregation propensity.
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Zusammenfassung
Proteine sind komplexe organische Verbindungen von hohem Moleku-
largewicht, die an den unterschiedlichsten und fundamentalsten Prozessen
lebender Organismen beteiligt sind. Um ihre Funktion auszuu¨ben, mu¨ssen
sich Proteine in eine eindeutige dreidimensionale Struktur falten, den soge-
nannten nativen Zustand, welcher einzig und allein durch die Aminosa¨ure-
sequenz eines Proteins bestimmt ist. Der native Zustand ist die U¨bersetzung
der genetischen Information und entspricht der Bedeutung der Sequenz in
der Sprache der Proteine. Aus Sicht der statistischen Mechanik entspricht
die Faltungsreaktion einer Diffusion eines Ensembles von Polypeptidketten
auf einer trichtera¨hnlichen Energielandschaft. In diesem Zusammenhang
stellt die vollsta¨ndige Beschreibung der freien Energielandschaft eines Pro-
teins eine effektive Art dar, die thermodynamischen und kinetischen As-
pekte der Proteinfaltungsreaktion zu beschreiben und o¨ffnet den Weg zum
Knacken des ”Proteincodes”.
Zur Zeit ist es noch nicht gru¨ndlich verstanden, welche Vorgu¨nge zur Bildung
von geordneten Peptid- und Proteinaggregaten fu¨hren.
Der Schwerpunkt dieser Dissertation war die Erforschung der
physikalisch-chemischen Eigenschaften der Aminosa¨uren, welche die Beta-
Faltblatt Aggregation begu¨nstigen. Daru¨ber hinaus wurden zwei param-
eterfreie Formeln fu¨r die Vorhersage der Aggregationsraten vorgeschlagen
(Kapiteln 3, 4, und 5). Zu den Verfahren, die fu¨r die Herleitung der Modelle
benutzt wurden, za¨hlen unter anderem: die Analyse von beta-aggregierenden
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Peptidsequenzen, welche durch im Sequenzraum optimierte genetische Al-
gorithmen modelliert wurden und die Erforschung des Konforma-
tionsraums durch Moleku¨ldynamiksimulationen (Kapitel 2).
Die beobachtete hohe Korrelation zwischen vorhergesagten und gemessenen
Aggregationsraten weisen darauf hin, dass unsere Modelle in vitro Experi-
mente mit hoher Genauigkeit beschreiben.
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Chapter 1
Introduction
1.1 Protein Molecules
Amino Acids
Amino acids consist of a primary amine bound to an aliphatic atom (called
the α-carbon, or Cα), which in turn is bound to a carboxylic acid group. The
Cα bears a side chain which is different for different amino acids. Proteins
are linear polymers of amino acids linked via a peptide bond which consists
of a carbonyl group’s carbon atom directly bound to the nitrogen atom of
a secondary amide. The peptide chain has an unbound amino group free at
one end (called the N-terminus) and a single free carboxylated group at the
other end (called the C-terminus). While there are theoretically billions of
possible amino acids, natural proteins are formed from only 20 amino acids
(called proteogenic). The side-chains of proteogenic amino acids are quite
varied: they range from a single hydrogen atom (as for glycine, the simplest
amino acid) to bicyclic groups, as for tryptophan. In fact, the 20 amino
acid side chains show different physicochemical properties such as polarity,
acidity, basicity, aromaticity, bulkiness, conformational flexibility, ability to
cross-link, ability to hydrogen bond, and chemical reactivity. These char-
acteristics, many of which are interrelated, are largely responsible the wide
range of protein properties.
The information contained in the amino acid sequence (called primary
structure) is enough to guide a protein to fold into its three-dimensional
structure (called the “native state”) [1], to determine its specificity for in-
teraction with other molecules [2, 3] and to set its lifetime and stability with
7
respect to the unfolded state [4]. The protein function is almost completely
dependent on protein structure [5, 6]. Enzymes must recognize and react
with their substrates with precise positioning of critical chemical groups in
the three-dimensional space. Scaffold proteins must be able to dock other
proteins or components precisely and position them in space in the correct
way. Structural proteins like collagen must face mechanical stresses and be
able to build a regular matrix where cells can adhere and proliferate. Motor
proteins must reversibly convert chemical energy into movement in a precise
fashion.
Protein Folding
Almost a half century ago, Pauling discovered two quite simple, regular ar-
rangements of amino acids, the α-helix and the β-sheet, which have become
known as the main components of the secondary structure of proteins [7].
In the protein core, the secondary structure provides a way to preserve hy-
drogen bonding of the peptide backbone by forming regular and repeating
structures. The folding of secondary structural elements together with the
spatial arrangement of the side chains is known as the tertiary structure. As
many proteins are composed of two or more polypeptide chains which asso-
ciate through non-convalent interactions and disulfide bonds, the description
of the spatial arrangements of these chains is called the quaternary structure.
Folding depends a great deal on the characteristics of a protein’s sur-
ronding solution, including the identity of the primary solvent (either water
or lipid inside cells), the salt concentration, the temperature, and molecular
chaperones [8]. In an aqueous environment, proteins fold in order to put as
much of the hydrophobic amino acid side chains out of contact with water
as possible. This provides much of the driving force for protein folding and
protein-protein interactions. Generally, polar amino acid side chains parte-
cipate in hydrogen bonding to water, while hydrophobic side chains interfere
with it. In fact, protein structure (and also the interactions between pro-
teins and other molecules) may be regarded as a compromise. On the one
hand, it may be necessary to sacrifice a hydrogen bond or two to gain two
or three hydrophobic interactions. On the other hand, it may be necessary
to place a hydrophobic residue in contact with water in order to pick up a
few more hydrogen bonds in the secondary structure [9, 10, 11]. Among the
interactions that provide protein’s stabilization [12, 13, 14] we can include:
• Hydrophobic interactions
• van der Waals interactions
• London dispersion forces
• Hydrogen bonds
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• Charge-charge interactions
Among the unfavorable interactions we can highlight:
• Removing a polar group from water without forming a new hydrogen
bond to it
• Removing a charged group from water without putting an opposite
charge nearby or putting two like charges close together
• Leaving a hydrophobic residue in contact with water
• Putting two atoms in the same place (steric exclusion)
• Organizing anything into a structure (decreasing entropy)
For a 100-residue protein, it is possible to estimate roughly that the
sum of all the favorable interactions that stabilize the three-dimensional,
native structure is of the order of -500 kcal/mol . On the other hand, the
sum of all the unfavorable interactions that destabilize the structure is ap-
proximately +480 kcal/mol. The net result is that the three-dimensional
structure of a typical protein is only about -10 to -15 kcal/mol more sta-
ble than the structureless state. In fact, proteins can lose their structure if
put in unsuitable chemical (e.g., high or low pH; high salt concentrations;
hydrophobic environment) or physical (e.g., high temperature, high pres-
sure) conditions [15, 16]. This process is called denaturation. Denatured
proteins have no defined secondary and tertiary structures and, expecially if
concentrated, tend to aggregate into insoluble masses. Many of these aggre-
gates have a common morphology known as amyloid fibrils which are regular
fibrillar structures that are micrometers in length, a few nanometers in di-
ameter [17, 18]. Amyloid fibrils are composed of an intramolecular β-sheet
core running perpendicular to the fibril axis [19, 20].
Experimental work in the mechanism of protein folding has been greatly
influenced by Levinthal’s famous paper of 1969 [21], in which he pointed
out that a polypeptide chain would require an astronomical amount of time
to explore at random all possible conformations in order to finally reach
the native state [22, 23, 24]. This motivated the search for partially folded
intermediates that guide the protein to the native state [25, 26]. Importantly,
the slowest folding proteins require many minutes or hours to fold. However,
small proteins, with lenghs of hundred or so amino acids, typically fold on a
millisecond time scale [27]. The very fastest known protein-folding reactions
are complete within a few microseconds [28, 29].
Thermodynamics and Kinetics
Since the late 1980s, a theoretical approach to protein folding has been
the calculation of protein energy landscapes [30]. The energy landscape of a
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protein is the variation of its free energy G as a function of its conformation,
owing to the interactions between the amino acids residues. The free energy
change ∆G is a balance of two terms:
∆G = ∆H − T∆S
where:
• ∆H = enthalpy, i.e., net amount of energy available from changes in
the bonding of the reactants and products. If heat is given off, the
reaction is favorable (∆H < 0).
• ∆S = entropy, i.e., change in the amount of order during the reaction.
Order is unfavorable (∆S < 0). Disorder is favorable (∆S > 0).
Protein folding and aggregation can be thought as chemical reactions, in
which the evolution of the atoms over time provides a complete description
of both the thermodynamics and kinetics [31]. Before a reaction can happen,
the individual molecules must have enough thermal energy to make or break
the chemical bonds as required in the selected chemical reaction. In fact,
the reaction can be viewed as being blocked by a barrier: If the barrier is
low, the reaction is fast but if the barrier is high, the reaction is slow. For a
generic reaction A→ B (examples include: A could be the native state of a
protein and B its unfolded state, A could be the unfolded state of a protein
and B its β-sheet fold, A could be the aggregated state of a certain amount
of peptides and B their dissociated state, etc.) the energy that a protein
must gain to cross over the barrier is called the free energy of activation.
Transition state theory tells us that when a molecule of a reactant has enough
energy to jump the barrier, the molecule’s structure is intermediate between
that of the substrate and that of the product [32, 33, 34]. Importantly, the
activation energy determines how fast a given reaction happens. The speed,
or rate, of the formation of B or the disapperance of A is usually found to
be proportional to the concentration of A that is present at the time the
velocity is measured:
κ = −d[A]
dt
= ν[A]
This equation is known as a rate law and relates how the rate of the reaction
depends on the concentration(s) of the substrate. In this case k must have
units of molar per second (M/s) and [A] has molar units (M), therefore ν
must have units of reciprocal seconds (1/s). Since the reaction rate decreases
as the substrate is used up, the plot of [A] against time is a curved line; the
slope decreases exponentially with time:
A = A0 e
−νt
where A is the concentration of the substrate A at any time t, A0 is the
initial concentration of A at t = 0, and ν is the rate constant.
10
Energy Landscapes
It has been proposed that natural proteins have evolved such that the com-
plicated free-energy surface has a funnelled shape which leads towards the
lowest free-energy conformation available to the protein [35]. The funnel
landscape allows the protein to fold to the native state through any of a
large number of pathways and intermediates, rather that being restricted
to a single mechanism [36, 37, 30]. The theory is supported by computa-
tional simulations of model proteins and has been used to improve methods
for protein structure and design [38, 39, 40, 22]. Experimental techinques
provide much of the information relative to the free-energy landscape:
• Fluorescence and infrared sprectoscopy (IR) capture the early events
in protein folding on a submillisecond time scale [41, 42].
• X-ray and NMR spectroscopy determine interactions between individ-
ual atoms providing insights on the location of active sites, catalytic
mechanisms, and conformational changes. [43, 44, 45].
• Far-and near-UV circular dichroism (CD) determine the average con-
tent of the secondary structure and monitor the packing of aromatic
side-chains that determine conformational changes in the protein dur-
ing folding [46].
• Single molecule detection (SMD), and in particular atomic force
microscopy (AFM), total internal reflection fluorescence microscopy
(TIRFM), optical-trapping nanometry, polarized fluorescence and flu-
orescence resonance energy transfer (FRET) monitor the time evolu-
tion of single biomolecules during their functional activity allowing the
detection of global movements and conformational changes [47, 48, 49].
Molecular Dynamics
Current experimental strategies are not sufficient to provide all the informa-
tion required to describe the protein free-energy landscapes: X-ray and NMR
experiments do not allow the complete exploration of non-native structures,
CD and AFM techniques are generally limited by the time required or on
the space resolution. One of the principal tools to determine protein struc-
tures from X-ray crystallography and from NMR experiments is the method
of molecular dynamics simulations. This computational method calculates
the time dependent behavior of a molecular system and provides detailed
information on the fluctuations and conformational changes of proteins and
nucleic acids. The core of the molecular dynamics algorithm is the the po-
tential energy function (force field). Current generation force fields provide a
reasonably good compromise between accuracy and computational efficency
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and are calibrated to experimental results and quantum mechanical calcu-
lations of small model compounds. The development of parameter sets for
the force field is a very laborious task that requires extensive optimization.
Force fields show certain limitations. As an example, no drastic changes in
electronic structure are allowed, i.e., no events like bond making or break-
ing can be modeled. Nevertheless, molecular dynamics has been successfully
applied to study the reversible folding of structured peptides [50, 51, 52, 53].
In agreement with experiments in vitro, three replicas of the Sup35 yeast
prion fragment GNNQQNY have been shown to form a β-aggregated structure
by molecular dynamics simulations [54, 55]. The investigation of the free
energy of the system has indicated a highly rugged surface with minima
corresponding to β-aggregate structures. Moreover, the parallel configura-
tion, in which all of the peptides have the same orientation, characterizes
the global minimum. Other configurations corresponding to different pep-
tide orientations (including the antiparallel arrangement) identify several
free-energy local minima [54].
1.2 A Computational Study on the
β-Aggregation
The above mentioned system of three β-aggregated heptapeptides is the
object of the study presented in Chapter 2, in which molecular dynamics
simulations are combined with a genetic algorithm optimization to inves-
tigate the β-aggregation propensity of several amino acid sequences. The
work aims to determine the information encoded in the β-aggregated struc-
tures and thus identify the polypeptide sequences that are susceptible to
having a stable minimum in the β-aggregated state. Intriguingly, all the
sequence mutations that lead to the disaggregation of the system represent
straightforward candidates for the inhibition of amyloidogenic natural pro-
teins.
Broadly speaking, working with genetic algorithms has the potential to
be a philosophically and epistemologically-interesting iterative process. In
the first step, the process of evolution occurring spontaneously in nature
is observed. Next, principles of evolution are converted into computer pro-
grams. To complete the recursive cycle, computational genetic algorithms
are applied to the very objects, i.e., proteins, from which they were derived
in the beginning. In fact, the genetic algorithm is a heuristic method that
operates on pieces of information just as nature does on genes in the course
of evolution. Individuals are represented by a linear string of letters of an
alphabet (in nature they are nucleotides, in genetic algorithm they are bits,
characters, strings, numbers or other data structures) and are allowed to
mutate, crossover and reproduce. All the individuals of one generation are
evaluated by a fitness function. Depending on the generation replacement
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mode a subset of parents and offspring enters the next reproduction cycle.
After a number of iterations, the populations consists of individuals that are
well adapted in terms of the fitness function.
In our case, the genetic algorithm searches the space of sequences for
the ones that have the best match to a particular three-dimensional target
conformation (a parallel or an antiparallel β-sheet aggregate of three hep-
tapeptides [54]). For each peptide sequence, three replicas are submitted
to a 330 K molecular dynamics simulation, starting from the β-aggregated
conformation. A non physiological temperature of 330 K is used to ob-
tain enough sampling within the time scale of the simulations [54]. Peptide
sequences are ranked according to their ability to prevent disaggregation.
The disaggregation fitness function is estimated for each sequence to be the
number of snapshots whose Cα root mean square deviation (RMSD) from
the template is lower than 1 A˚. The best matches, called best parents, are
replicated and subjected to mutation and crossover: 1632 sequences have
been studied for a total of 81µs of simulation.
Amyloid Fibrils
The above mentioned system of three β-aggregated heptapeptides can be
only distantly compared to the long, twisted, and intertwined amyolid fibrils
found in vivo. As shown by experiments in vitro that use circular dichroism
and Fourier transform intra-red spectroscopy (FTIR), amyloid fibrils have
a high content of β-structure, even when the monomeric peptide or protein
is substantially disordered or rich in α-helical structure [56]. Investigations
of the fibrils using electron and atomic force microscopy show that they
are typically straight and unbranched. The fibrils are typically 6–12 nm in
diameter and usually consist of two to six protofilaments, each of a diameter
∼ 2nm, which are often twisted around each other to form supercoiled
rope-like structures. Each protofilament in such structures appears to have a
highly ordered inner core, which X-ray fiber diffraction data suggest consists
of some or all of the polypeptide chain arranged in a charactersitic cross-β
structure. In this structural arrangement, the β-strands run perpendicular
to the protofilament axis, resulting in a series of β-sheets that propagate
along the direction of the fibril (Figure 1.1) [18, 57, 58] .
Amyloid Diseases
Incorrectly folded proteins are responsible for prion related illness such as
Creutzefeldt-Jakob disease and Bovine spongiform encephalopathy (Mad
Cow disease), and amyloid related illnesses such as Alzheimer’s disease.
These diseases are caused by misfolded proteins aggregating into insolu-
ble proteins. The discovery of protein aggregation diseases, where multiple
proteins sacrifice contacts with the native state in favor of inter-chain con-
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tacts with neighboring proteins, suggests that some proteins have aggregated
states that are thermodynamically equal if not more favorable than the na-
tive state. Until about 30 years ago, proteolysis was considered to be the
primary factor for the formation of amyloid aggregates in vivo, following
the demonstration that lysosomal enzymes, at acidic pH values, are able
to convert amyloidogenic proteins into amyloid fibrils [61]. The perspective
changed around 10 years ago when it was shown that thransthyretin can be
converted in vitro into amyloid fibrils following an acid-induced conforma-
tional change [62]. In 1998, a protein unrelated to any amyloid disease was
found to form structures indistinguishable from the amyloid fibrils produced
from the disease-associated proteins [63, 64]. In fact, under certain condi-
tions it has been shown that any polypeptide chain can form fibrils [65, 66].
The various peptides and proteins associated with amyloid diseases have no
obvious similarites in size, amino acid composition, sequence or structure.
Nevertheless, the amyloid fibrils into which they convert have marked simi-
larities both in their external morphology and in their internal structure.
Prions: The most interesting example of a protein folding disorder is
Mad Cow disease and its human equivalent, the Creutzefeldt-Jakob disease.
These diseases, along with the sheep version known as scrapie, have had the
scientific community in uproar for years. They are all infectious diseases
which are transmitted by prions, i.e., protein particles. Prions seem to be
pure protein; they contain neither DNA nor RNA. However, an infectious
agent must by definition be self-replicating [67, 68, 69]. The protein whose
aggregation damages cells in Mad Cow disease is constantly being produced
by the body. Normally, it folds properly, remains soluble, and is disposed
out without problem. When a small amount of it misfolds in a particular
way so as to become a scrapie prion, this prion bumps into a normal-folding
intermediate, shifts the folding progress in the scrapie direction and the
protein, despite its perfectly normal amino acid sequence, also ends up as
scrapie prion [70, 71, 72]. In this manner the process continues: So long as
the body keeps producing the normal protein, a little bit of scrapie prion
can keep on creating more and then even more of itself. In effect, the prion
is replicating itself without needing any nucleic acid of its own. When seed
quantities of two different scrapie prion strains are mixed in separate test
tubes with large amounts of normal protein, each test tube produces more
of the specific scrapie prion strain that was added. Each strain induces the
normal protein to fold in exactly the same way as the original seed [73]. The
strain breeds in the test tube, just as it does in the body.
Alzheimer’s Disease: Alzheimer’s disease aﬄicts 10 percent of those over
65 years old and perharps half of those over 85. In 1991, several different
research groups found that individuals with specific mutations in their amy-
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loid precursor protein developed Alzheimer’s disease as early as age 40. The
body processes amyloid precursor protein into a soluble peptide known as
Aβ; under certain circumstances, Aβ then aggregates into long filaments
that cannot be cleared by the body’s usual scavenger mechanisms. These
aggregates then form the β-amyloid, which make up the neuritic plaque in
Alzheimer patients [74, 75, 76]. So the consistent association of amyloid
preursor protein mutations with early-onset Alzheimer’s disease has finally
answered a long-debated question: the deposition of neuritic plaque is part
of the pathway leading to the disease and not a late consequence of it. To
help understand the Aβ aggregation process, researchers chemically syn-
thesized fragments of the 40-amino-acid-long peptide [77, 78]. Specifically,
the precursor fragments have to form a specific nucleus, which then prop-
agates the amyloid process. Possibly the slowness of this first step is why
Alzheimer’s disease is almonst entirely limited to older people, and it could
be that the mutations in amyloid precursor protein that lead to early-onset
Alzheimer’s are the ones that make it progress more quickly and easily in
vivo.
1.3 Aggregation Rate Prediction
As explicitly mentioned for Alzheimer’s disease, the speed of the β-
aggregation represents a crucial factor in the evolution of all the amyloid-
related pathologies [79, 80]. However, it has been recently shown that the
amyloid fibril formation is not a property limited to a selected few pro-
teins and that under certain conditions any polypeptide chain can form
fibrils [65]. In fact, single amino acid substitutions have been used to in-
vestigate the fibril formation of the human muscle acylphosphatase protein
(AcP) [66]: The small α/β protein was converted from a soluble and native
form into insoluble amyloid fibrils in a solution containing moderate con-
centrations of trifluoroethanol. When analysed with electron microscopy,
the AcP aggregate present in the sample after long incubation time consists
of extented, unbrached filaments of 30–50 A˚ in width that assemble into
higher-order structures. The fibrillar material was shown to possess exten-
sive β-sheet structure as revealed by far-UV circular dichorism and infra-red
spectroscopy. Furthermore, the AcP fibrils exhibit Congo red birefringence,
increased fluorescence with thioflavin T and cause a red-shift of the Congo
Red adsorbtion spectrum, which are characteristics typical of amyloid fib-
rils [81]. On the basis of this experiment, an empirical equation was proposed
to explain changes of the aggregation rate upon amino acid mutations [82].
The high correlation found between rate and simple physicochemical prop-
erties (such as the β-propensity, charge, and hydrophobicity) is the original
motivation for the work presented in Chapter 3.
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The Relative Rate Equation
In Chapter 3, we report a fomula to predict the change of aggregation
and disaggregation rate upon amino acid mutation. In the derivation of
the model, we used simple physicochemical properties of amino acids, such
as the polar and apolar water-accessible surface areas, the pi-stacking inter-
action of aromatic residues, the dipole moment, the β-propensity, and the
charge. The model is parameter-free, i.e., to have the most possible general
equation, we did not use parameters that need to be estimated from exper-
iments. Human muscle acylphospatase (AcP), islet amyloid polypeptide,
prion peptides, α-synuclein, amyloid β-peptide, tau, leucine-rich repeat and
other model peptides were used to test the equation: A correlation of 85%
was found, indicating high agreement with experimental data (Figure 1.2).
Furthermore, the equation was applied to predict the disaggregation rate
of sequences generated by genetic algorithm optimization (see also Chap-
ter 2) with a correlation of 80%. The fact that the model can be applied
to describe both aggregation and disaggregation rates is a consequence of
the very general functional form of the equation. Moreover, the absence of
fitting parameters permitted the use of the same equation for the descrip-
tion of experiments in vitro and in silico, indicating that the method suites
general application.
The Absolute Rate Equation
Although the application of the relative rate equation shows high correla-
tion with experimental data, this models requires the a priori knowledge
of the wild-type aggregation rate. In Chapter 4, we report an absolute
rate equation derived from both first principles and analysis of aggregating
sequences designed by a computational approach. The model gives both the
aggregation rate and the ‘amyloid spectrum’ of a protein, identifying those
segments involved in β-aggregation (Figure 1.3). Compared with models
published by others [82, 83, 84], our equation is the only one which has been
derived to predict β-aggregating segments in different polypeptide chains.
In agreement with results obtained by genetic algorithm optimization in se-
quence space and molecular dynamics sampling of conformation space (see
also Chapter 2), our model distinguishes between the parallel and antipar-
allel β-sheet organization within the fibrils, giving interesting insights into
their structure. We also found that mammalian and non-mammalian prion
proteins have different amyloid spectra. More specifically, the absence of the
fragment SNQNN, present in mammalian prions, decreases the overall ag-
gregation propensity of non-mammalian prions, indicating a species-specific
behaviour consistent with experiments [85, 86] and supporting the hypoth-
esis of a species barrier in the transmission of the prion disease [87].
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Evolutionary Trends for the β-Aggregation
Intrinsically disordered proteins represent one of the major structural differ-
entiations between proteins of mono- and multicellular eukaryotes [88, 89].
Unstructured proteins are largely present in higher eukaryotes, indicating
that the native protein’s function depends on a structural ensemble rather
than an unique three-dimensional structure. Regions lacking specific
three-dimensional structures have been associated with 28 distinguishable
functions, ranging from DNA-binding to display of sites for phosphoryla-
tion to preventing interaction by means of excluded volume effects [90]. In
Chapter 5, we report a novel approach to compare proteomes based on
the statistical analysis of β-aggregation propensity. From P. tetraurelia to
H. sapiens, we show that proteomes of multicellular and more long-lived
eukaryotes contain fewer sequences with high β-aggregation propensity and
are accumulated in protein with low β-aggregation propensity (Figure 1.4).
We observed that compared to random proteomes, natural proteomes are
enriched in proteins with low β-aggregation potential as well as proteins
with high β-aggregation potential. Such polarization is a consequence of the
dual evolutive requirement of intrinsically disordered proteins with low β-
aggregation propensity as well as proteins with a stable fold which comes at
the cost of higher β-aggregation propensity. The functional role of aggrega-
tion phenotypes in multicellular eukaryotes is still a matter of debate [91, 92].
In the future, we plan to use gene ontology annotations of proteins with high
predicted β-aggregation propensity to obtain insights on the specific role of
some of the amyloidogenic proteins of unknown function.
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Fig. 1.1: Top plot: Transmission electron microscopy of a mesh of amyloid
fibrils assembled from human lysozyme negatively stained with uranyl ac-
etate [59]; Bottom plot: Schematic drawing of the structural organisation
of insulin fibrils. The image shows a fibril with four protofilaments wound
around each other. In this model the core structure of each protofilament is
a row of β-sheets, here running antiparallel [60].
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Fig. 1.2: Calculated versus observed changes in aggregation rate upon mu-
tation: AcP (28 triangles) and heterogeneous groups of peptide and protein
systems including islet amyloid polypeptide, prion peptides, α-synuclein,
amyloid β-peptide, tau, leucine-rich repeat and some model peptides (27
circles).
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Chapter 2
A Computational Study on
the β-Aggregation
Aggregation properties of 1632 peptides are studied by using the genetic
algorithm Lila, written by G.G. Tartaglia. Lila searches the space of se-
quences for those which have the best match to a certain three-dimensional
structure providing results which are largely discussed in Chapter 3, 4, and
5.
2.1 Genetic algorithm optimization
Aggregation propensities of small peptides are investigated with a genetic
algorithm optimization in sequence space and molecular dynamics sampling
of conformation space. As target structures for the optimizations we used
the parallel and the antiparallel β-sheet conformations of three aggregated
replicas of the Sup35 yeast prion peptide GNNQQNY [1] (Figure 2.1):
• For each peptide sequence, three replicas are submitted to a molecular
dynamics simulation starting from the target conformation.
• Peptides sequences are ranked according to their ability to prevent
disaggregation using the fitness function. The fitness function for each
sequence is estimated to be the number of snapshots whose Cα root
mean square deviation (RMSD) from the template is lower than 1 A˚.
• The best matches are replicated and subjected to mutations and cross
over.
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Fig. 2.1: Aggregation of three heptapeptides: a parallel, b mixed, and c
antiparallel conformation [1].
Molecular Dynamics
Objective Function
Replication
Crossover
Mutations
 Pool of Chromosomes
LILA
(Start Here)
Fig. 2.2: Sketch of the genetic algorithm optimization (LILA).
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2.2 Molecular dynamics
The MD simulations and part of the analysis of the trajectories were
performed with the CHARMM program [2]. The oligomeric peptide systems
were modeled by explicitly considering all heavy atoms and the hydrogen
atoms bound to nitrogen or oxygen atoms (PARAM19 potential function [2,
3]). The remaining hydrogen atoms are considered as part of the carbon
atoms to which they are covalently bound (extended atom approximation).
The effective energy, whose negative gradient corresponds to the force used
in the dynamics, is:
E(r) = Evacuum(r) +Gsolv(r)
for a molecular system with atomic nuclei located at r = (r1, ..., rN ). In
vacuo, the PARAM19 energy function is:
Evacuum(r) =
1
2
∑
bonds
kb(b− b0)2 + 1
2
∑
bond angles
kθ(θ − θ0)2
+
1
2
∑
dihedral angles
kφ[1 + cos(nφ− δ)]
+
1
2
∑
improper dihedrals
kω(ω − ω0)2
+
∑
i>j
mini j [(
dminij
rij
)12 − 2(d
min
ij
rij
)6]
+
∑
i>j
qiqj
(rij)rij
where b is a bond length, kθ a bond angle, φ a dihedral angle, kω an im-
proper dihedral, rij is the distance between atoms i and j, qi and qj are
partial charges, and dminij and 
min
ij are the optimal van der Waals distance
and energy, respectively. An implicit model based on the solvent accessible
surface was used to describe the main effects of the aqueous solvent on the
solute [4]. In this approximation, the solvation free energy is given by:
Gsolv(r) =
N∑
i=1
σiAi(r)
for a molecular system having N heavy atoms with Cartesian coordinates
r = (r1, ..., rN ). Ai(r) is the solvent-accessible surface computed by an
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approximate analytical expression and using a 1.4 A˚ probe radius. The sol-
vation model contains only two σ parameters: one for carbon and sulfur
atoms (σC,S = 0.012 kcal/mol A˚), and one for nitrogen and oxygen atoms
(σN,O = −0.060 kcal/mol A˚). Hydrophobic side chains tend to be buried
within the solute whereas hydrophilic side chains and the polar groups of the
backbone prefer to be solvent accessible. Furthermore, ionic side chains were
neutralized and a linear distance-dependent screening function (rij) = 2rij
was used for the electrostatic interactions. The PARAM19 default cutoffs
for long range interactions were used, i.e., a shift function was employed
with a cutoff at 7.5 A˚for both the electrostatic and van der Waals terms.
This cutoff length was chosen to be consistent with the parameterization of
the force-field and implicit solvation model. The model is not biased toward
any particular secondary structure type. In fact, exactly the same force field
and implicit solvent model have been used recently in MD simulations of ag-
gregation and folding of structured peptides [5, 6] (α-helices and β−sheets)
ranging in size from 15 to 31 residues [7, 8], and small proteins of about 60
residues [9, 1].
2.3 Lila’s set up and performances
In two independent runs of Lila, a pool of 48 sequences is subjected to
17 evolutionary cycles: 1632 sequences are generated, for a total amount of
81µs of molecular dynamics simulation (Figure 2.2).
• First cycle: Sequences are generated randomly.
• Molecular dynamics: Each peptide sequence is submitted to 50ns
molecular dynamic simulation with implicit solvent (see previous
section). A non-physiological temperature of 330 K is used to obtain
enough sampling in the time scale of the simulations [1]. In order to
optimize the CPU time, no periodic boundary conditions are used and
peptides are free to separate. To avoid long-distance calculations, we
measured the fitness as the number of snapshots whose Cα−RMSD
from the template is lower than 1 A˚.
• Best parents: For each evolutionary cycle three best matches are se-
lected. The best parent nr. 1 has the highest fitness function, followed
by the best parent nr. 2 and the best parent nr. 3.
• Replication: 50% of the pool is filled by replicas of the best parent
nr. 1, 30% by replicas of the best parent nr. 2, and 20% by replicas
of the best parent nr. 3.
• Cross over: Two by two, all the sequences are subjected to ran-
dom cross over. One replica of the best parents remains unchanged
(elitism).
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Fig. 2.3: Lila’s performances for the parallel and the antiparallel β-sheet
aggregation. For a total of 17 cycles, the fitness function is estimated to be
the number of snapshots whose Cα-RMSD from the template is lower than
1 A˚.
• Mutations: All the sequences are subjected to random mutations.
For each sequence the mutation involves from zero to three amino
acid modifications (assigned randomly).
The performances of Lila are reported in Figure 2.3. For each evolu-
tionary cycle, the average of the fitness displays a monotonic trend, which
points out the effective optimization of the population. Moreover, the av-
erage and the dispersion of the fitness are found proportional (Plots a and
c of Figure 2.3), indicating that there is no premature convergence to non-
optimal solutions. Plots b and d of Figure 2.3 show that the fitness of the
best parents reaches the maximum value of 0.7 for the parallel optimization
and 0.9 for the antiparallel optimization (Table 2.2).
In the optimizations, amino acid changes follow specific patterns. In se-
quences selected for the parallel β-sheet aggregation the number of aliphatic
and aromatic residues increases almost monotonically, while the number
of charged and polar residues decreases. The opposite is observed in se-
quences selected for the antiparallel β-sheet aggregation (see Figure 2.4).
The analysis indicates that parallel aggregates are stabilized by hydropho-
bic interactions (mainly pi-stacking of aromatic residues), while antiparallel
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Fig. 2.4: Trends of amino acid properties for the parallel and antiparallel
optimizations. In the plots, the number of aliphatic, aromatic, charged, and
polar residues is normalized by the length of the peptide and averaged over
the population.
aggregates are stabilized by electrostatic interactions (mainly dipole-dipole
interactions).
Sequences selected for the parallel β-sheet aggregation show high iden-
tity with fragments of the Alzheimer’s Aβ40 [10]. In particular, we found
that 160 sequences have three matches with the fragment QKLVFFA and 20
sequences have four matches with HQKLVFF which is also known to be amy-
loidogenic [11]. We also found the sequences HFWLVFF and FFVLYQH which
display five and six inverted matches with with the fragment HQKLVFF. By
considering that the genetic algorithm sampled 816 sequences during the op-
timization of the parallel aggregation and a random search approximately
needs 107 sequences to scan before finding six matches, we conclude that the
genetic algorithm approach performs 104 better than random. Compared to
known amyloidogenic fragments [12], sequences selected for the antiparallel
aggregation show no significant matches.
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Sequencea Fitness Sequencep Fitness
YNTIVDF 0.33 LQYQMLY 0.17
YATIDRY 0.44 YEWLKRY 0.33
KVTCDRY 0.50 YVWYKFY 0.37
KVTCDRY 0.50 LWYQMYY 0.42
KVTCDRY 0.50 LWYQKFY 0.48
KVTCDRY 0.50 AWYQKFY 0.55
KVTCDRY 0.50 YAWYKFY 0.58
KVTSNVY 0.59 YAWLKFY 0.58
KDTQDRY 0.69 YAWLKFY 0.58
KDTQDRY 0.69 YAWLKFY 0.58
YDCQDFY 0.79 YEWLKFY 0.61
TDTQDFE 0.84 YFWLKFY 0.64
TDTQDFE 0.84 YFWLKFY 0.64
TDTQDFE 0.84 MFWLYFY 0.72
TDTCDWQ 0.90 MFWLYFY 0.72
TDTCDWQ 0.90 MFWLYFY 0.72
TDTCDWQ 0.90 MFWLYFY 0.72
Tab. 2.2: Sequence and fitness of best parents nr. 1. The labels a and p
indicate peptide sequences whose optimized β-aggregated conformation is
antiparallel or parallel, respectively.
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2.4 Fibril formation
Peptide sequences are optimized by Lila to prevent disaggregation. In
order to test the aggregation propensity of best parents, we performed molec-
ular dynamics simulations of the peptides YDCQDFY, TDTQDFE, and TDTCDWQ
(selected for the antiparallel β-sheet aggregation) as well as of the peptides
YEWLKFY, YFWLKFY, and MFWLKFY (selected for the parallel β-sheet aggrega-
tion). For each peptide, three replicas are randomly placed in a cubic box of
75X75X75 A˚3 and submitted to a 330 K molecular dynamics simulation of
1µs using periodic boundary conditions. Figure 2.5 displays the histogram
of Π, i.e., the number of snapshots whose Cα-RMSD from the parallel or
antiparallel target structure is lower than 1 A˚. Except for YDCQDFY, all the
best parents show a main peak in corrispondence of Π ∼ 1, which indi-
cates the predominance of ordered aggregates. As expected, the peptides
YEWLKFY, YFWLKFY, and MFWLKFY form parallel aggregates, while the peptides
TDTQDFE and TDTCDWQ form antiparallel aggregates. The peptides TDTQDFE
and TDTCDWQ display a peak in corrispondence of Π ∼ 0.5, which indicates
the presence of a mixed parallel-antiparallel conformation (Figure 2.1), due
to the pi-stacking of aromatic residues [13]. Among the tested best parents,
the peptide YFWLKFY shows the highest tendency to the ordered aggregation.
Six replicas of the peptide YFWLKFY are submitted to a molecular dy-
namics simulation in the conditions explained above. Since no reference
structure is available for the fibril, we used two different variables to mon-
itor the aggregation progress: The orientation parameter P2 [14] and the
number of parallel and antiparallel Cα-contacts of the peptides (Figure 2.6).
The P2 parameter (defined in the range [0, 1]) indicates that all the pep-
tides take the same orientation, while the number of Cα-contacts (defined
in the range [0, 35]) displays the predominance of parallel contacts. The P2
parameter reaches a maximum at the value of 0.92, which points out the
presence of a fibril twist (Figure 2.7). Both the variables indicate that the
six replicas form a parallel β-sheet aggregate in 2.5µs, which is the stricking
consequence of the genetic algorithm optimization.
2.5 β-Aggregation Matrices
The β-aggregation propensity of sequences is investigated by using a pro-
cedure which was previously developed to estimate the energy of proteins
from the primary structure alone [15, 16]. Our approach allows the mea-
sure of side-chains contributions to the β-aggregation and can be applied to
compute the aggregation propensity of other sequences.
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Fig. 2.5: Aggregation simulation of best parents. The variable Π indicates
the number of snapshots whose Cα-RMSD from the parallel (black) or an-
tiparallel (red) target structure is lower than 1 A˚ is used to build the his-
togram.
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Fig. 2.7: Six replica peptides YFWLKFY forming a twisted fibril.
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Fig. 2.8: Parallel aggregation: The normalized fitness ϕp is used to train the
β-aggregation propensity matrix P
For computational reasons, the fitness f is transformed into the variable
ϕ, normalized in the interval [−1, 1]:
ϕ = 2
(
1
2
− f − fmax
fmin − fmax
)
where fmin and fmax are the lowest and the highest values of the fitness,
respectively. A value of ϕ close to 1 means f ∼ fmax, while a value of ϕ
close to −1 means f ∼ fmin. The variables ϕp and ϕa, corresponding to the
fitness for the parallel and the antiparallel aggregation, are used to compute
the matrices P and A:
ϕp
Cp→ P
ϕa
Ca→ A
where Cp and Ca are matrices which describe the side-chains contacts in
the aggregated parallel and antiparallel β-sheet conformation, respectively.
The two 20X20 symmetric matrices P and A describe the parallel and the
antiparallel β-aggregation propensity of the amino acid sequence:
ϕp '
∑
PijC
ij
p
ϕa '
∑
AijC
ij
a
Figures 2.8 and 2.9 show that ϕp and ϕa train the matrices P and A
with a correlation of 75% and 86%, respectively. The high correlations
39
-1 -0.5 0 0.5 1
ϕ
a
-1
-0.5
0
0.5
1
ΣA
ijC
ij
correlation=75%
Fig. 2.9: Antiparallel aggregation: The normalized fitness ϕa is used to train
the β-aggregation propensity matrix A.
found suggest that fitness values are not affected by statistical errors due to
insufficient molecular dynamics sampling and that sequences generated by
genetic algorithm optimization contain a signal which is largely superior to
noise. The matrix A shows lower correlation than the matrix B because of
the high number of low-fitness sequences (ϕa ∼ −1). In fact, the presence
of charged residues causes electrostatic interactions which are unfavorable
for several amino acid mutations.
The eigenvalues of A and P, sorted from the largest negative value λ1
to the largest positive value λ20, were used to determine the eigenvectors v
and write the diagonal form of ϕp and ϕa:
ϕp ∼ λ1p
∑
i,j
v1i (p)C
ij
p v
1
j (p)+λ
2
p
∑
i,j
v2i (p)C
ij
p v
2
j (p)+...+λ
20
p
∑
i,j
v20i (p)C
ij
p v
20
j (p)
ϕa ∼ λ1a
∑
i,j
v1i (a)C
ij
a v
1
j (a)+λ
2
a
∑
i,j
v2i (a)C
ij
a v
2
j (a)+...+λ
20
a
∑
i,j
v20i (a)C
ij
a v
20
j (a)
Since
∑
i,j v
1
iC
ijv1j > 0, the sign of the eigenvalue λ determines when
the corresponding eigenvector stabilizes (λ > 0) or destabilizes (λ < 0) the
β-aggregation. The eigenvector v20 provides the description of the most
stabilizing contributions. For the antiparallel configuration, the eigenvector
v20(a) shows that charged residues stabilize aggregation (Figure 2.10) and
displays a correlation of 70% with Eisenberg’s hydrophobicity scale [17].
For the parallel configuration, the eigenvector v20(p) indicates that aromatic
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Fig. 2.10: Eigenvector analysis. The two eigenvectors v20a and v
20
p respec-
tively correspond to the largest eigenvalues of the matrices A and P and
indicate that charged residues stabilize the antiparallel configuration and
aromatic residues stabilize the parallel configuration.
residues stabilize the parallel aggregation (Figure 2.10) and displays a cor-
relation of 70% with Mayo’s β-propensity scale [18]. We plan in the future
to use the matrices A and P to design new sequences.
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A C D E F G H I K L M N P Q R S T V W Y
A -2.57 -1.97 -1.63 1.71 -5.33 0.82 0.69 -0.45 -14.76 1.71 -9.20 0.21 0.00 -1.75 -0.72 -2.08 -1.55 -2.61 -3.66 -5.18
C -1.97 0.11 0.32 -0.02 -1.76 -0.10 0.20 -0.79 -3.04 -3.23 -1.91 1.48 0.00 -3.35 0.52 -0.83 -0.59 -0.10 -1.02 -2.79
D -1.63 0.32 -0.87 0.91 -2.47 0.77 0.19 0.16 -1.97 -1.09 -1.45 0.63 0.00 1.61 -0.81 0.68 1.41 0.43 -0.02 -3.86
E 1.71 -0.02 0.91 -1.34 2.03 -1.54 0.27 0.07 -0.44 1.52 0.07 -0.27 0.00 -0.81 -0.22 3.02 0.53 0.62 3.62 -2.38
F -5.33 -1.76 -2.47 2.03 4.63 -1.29 0.60 -1.29 4.12 2.44 4.69 1.22 0.00 3.23 2.84 -2.20 0.98 -1.84 -9.89 6.46
G 0.82 -0.10 0.27 -1.54 -1.29 -0.18 0.45 -0.23 -2.25 -7.41 -0.12 -0.20 0.00 -2.12 -0.06 -0.47 -1.54 -0.33 -1.27 -7.96
H 0.69 0.20 0.37 0.94 0.60 0.45 -0.73 0.56 -1.01 0.29 -0.64 0.41 0.00 -0.72 0.15 0.91 0.75 0.08 1.22 2.93
I -0.45 -0.79 0.16 0.97 -1.29 -0.23 0.56 -1.07 -1.77 0.98 -0.27 -0.06 0.00 0.67 0.20 0.21 0.03 -0.05 3.18 -1.44
K -14.76 -3.04 -1.97 -0.44 4.12 -2.25 -1.01 -1.77 -11.34 -10.09 -12.51 -2.65 0.00 -6.51 -5.33 -5.09 -1.14 -1.78 17.20 8.03
L 1.71 -3.23 -1.09 1.52 2.44 -7.41 0.29 0.98 -10.09 -2.81 0.46 -1.95 0.00 -8.91 0.30 -2.55 2.21 -2.98 8.52 -10.01
M -9.20 -1.91 -1.45 0.07 4.69 -0.12 -0.64 -0.27 -12.51 0.46 -2.06 -1.31 0.00 -3.10 -0.40 -3.03 -3.53 -3.02 7.42 -2.34
N 0.21 1.48 0.63 -0.27 1.22 -0.20 0.41 -0.06 -2.65 -1.95 -1.31 -0.88 0.00 0.85 0.02 -1.23 0.57 0.09 0.28 2.56
P 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Q -1.75 -3.35 1.61 -0.81 3.23 -2.12 -0.72 0.67 -6.51 -8.91 -3.10 0.85 0.00 -0.79 -0.25 -0.91 -0.67 0.09 2.19 -6.55
R -0.72 0.52 -0.81 -0.22 2.84 -0.06 0.15 0.20 -5.33 0.30 -0.40 0.02 0.00 -0.25 -0.71 0.74 -0.20 -0.63 3.56 -0.53
S -2.08 -0.83 0.68 3.02 -2.20 -0.47 0.91 0.21 -5.09 -2.55 -3.03 -1.23 0.00 -0.91 0.02 -0.73 0.54 0.84 0.87 -3.53
T -1.55 -0.59 1.41 0.53 0.98 -1.54 0.75 0.03 -1.14 2.21 -3.53 0.57 0.00 -0.67 -0.20 0.54 -2.40 0.96 4.70 -3.48
V -2.61 -0.10 0.43 0.62 -1.84 -0.33 0.08 -0.05 -1.78 -2.98 -3.02 0.73 0.00 0.09 -0.63 0.84 0.96 -0.25 0.69 -2.72
W -3.66 -1.02 -0.02 3.62 -9.89 -1.27 1.22 3.18 17.20 8.52 7.42 0.28 0.00 2.19 3.56 0.87 4.70 0.69 -9.82 6.36
Y -5.18 -2.79 -3.86 -2.38 6.46 -7.96 2.93 -1.44 8.03 -10.01 -2.34 2.56 0.00 -6.55 -0.53 -3.53 -3.48 -2.72 6.36 11.69
A C D E F G H I K L M N P Q R S T V W Y
A 0.06 -3.32 -1.21 -1.34 -2.49 -1.42 0.68 4.23 -0.66 0.27 1.22 -0.92 0.00 -1.64 -1.26 -0.92 -2.17 -1.12 -1.09 -1.81
C -3.32 4.82 -3.39 1.65 -3.39 -2.52 -0.05 0.70 -2.94 -2.29 -2.52 -2.84 0.00 -0.17 -1.37 -5.54 -8.53 1.99 -2.63 1.14
D -1.21 -3.39 -1.32 -0.30 2.84 -5.56 1.11 2.69 1.90 4.04 3.63 0.20 0.00 13.47 7.47 3.83 9.81 -2.40 6.18 10.50
E -1.34 1.65 -0.30 -1.54 -0.36 -1.23 1.04 -1.44 2.30 -0.31 -0.80 -1.10 0.00 -0.79 5.14 -2.01 2.74 -3.87 -3.92 -2.79
F -2.49 -3.39 2.84 -0.36 -1.70 -1.63 -0.64 -1.64 0.95 -1.11 1.89 0.21 0.00 0.93 -2.57 -1.32 -1.47 -2.16 -0.69 -3.46
G -1.42 -2.52 -5.56 -1.23 -1.63 -0.98 -0.49 -0.39 -0.05 -0.68 0.75 -0.27 0.00 -1.95 -2.43 -0.54 -3.08 -2.77 -0.87 -1.25
H 0.68 -0.05 1.11 1.04 -0.64 -0.49 0.43 -0.24 -1.55 -0.23 -1.52 -0.18 0.00 1.30 -0.96 -1.02 -0.31 -1.32 -0.76 0.05
I 4.23 0.70 2.69 -1.44 -1.64 -0.39 -0.24 0.18 0.45 0.74 0.18 1.30 0.00 -0.60 1.49 -1.41 2.18 0.99 -1.20 -3.62
K -0.66 -2.94 1.90 2.30 0.95 -0.05 -1.55 0.45 -3.37 2.60 -0.25 0.38 0.00 -4.44 -0.88 0.88 -6.72 -0.23 -2.18 3.65
L 0.27 -2.29 4.04 -0.31 -1.11 -0.68 -0.23 0.74 2.60 -1.54 -0.72 -0.49 0.00 0.14 -3.07 -1.00 1.54 0.41 -0.38 1.39
M 1.22 -2.52 3.63 -0.80 1.89 0.75 -1.52 0.18 -0.25 -0.72 0.47 1.38 0.00 1.35 -0.73 -1.29 -2.34 0.63 -0.73 -2.47
N -0.92 -2.84 0.20 -1.10 0.21 -0.27 -0.18 1.30 0.38 -0.49 1.38 0.42 0.00 0.66 -0.56 -1.40 -0.80 -1.62 -2.73 1.42
P 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Q -1.64 -0.17 13.47 -0.79 0.93 -1.95 1.30 -0.60 -4.44 0.14 1.35 0.66 0.00 0.41 -3.48 -3.68 4.35 0.55 -2.66 2.00
R -1.26 -1.37 7.47 5.14 -2.57 -2.43 -0.96 1.49 -0.88 -3.07 -0.73 -0.56 0.00 -3.48 -0.48 -0.08 -4.70 0.58 -3.93 -3.70
S -0.92 -5.54 3.83 -2.01 -1.32 -0.54 -1.02 -1.41 0.88 -1.00 -1.29 -1.40 0.00 -3.68 -0.08 -1.59 0.61 2.15 -3.15 -2.28
T -2.17 -8.53 9.81 2.74 -1.47 -3.08 -0.31 2.18 -6.72 1.54 -2.34 -0.80 0.00 4.35 -4.70 0.61 -0.90 2.33 -2.87 -2.29
V -1.12 1.99 -2.40 -3.87 -2.16 -2.77 -1.32 0.99 -0.23 0.41 0.63 -1.62 0.00 0.55 0.58 2.15 2.33 4.65 -3.58 -1.74
W -1.09 -2.63 6.18 -3.92 -0.69 -0.87 -0.76 -1.20 -2.18 -0.38 -0.73 -2.73 0.00 -2.66 -3.93 -3.15 -2.87 -3.58 -1.75 -1.35
Y -1.81 1.14 10.50 -2.79 -3.46 -1.25 0.05 -3.62 3.65 1.39 -2.47 1.42 0.00 2.00 -3.70 -2.28 -2.29 -1.74 -1.35 -7.08
Tab. 2.3: Parallel (top) and antiparallel (bottom) β-sheet propensity.
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Abstract
The mechanisms by which peptides and proteins form ordered aggregates are not well understood. Here we
focus on the physicochemical properties of amino acids that favor ordered aggregation and suggest a
parameter-free model that is able to predict the change of aggregation rates over a large set of natural
sequences. Furthermore, the results of the parameter-free model correlate well with the aggregation pro-
pensities of a set of peptides designed by computer simulations.
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Amyloid fibrils are involved in a number of diseases, in-
cluding Alzheimer’s disease, Parkinson’s disease, Hunting-
ton’s disease, prion disease, and type II diabetes (Kelly
1998; Rochet and Lansbury Jr. 2000). Therefore, it is of
fundamental medical interest to understand the mechanisms
of fibrillogenesis with the ultimate goal of designing inhibi-
tors. The amyloid fibril formation is not a property limited
to a selected few proteins: Under certain conditions it has
been shown that any polypeptide chain can form fibrils
(Dobson 1999). Because aggregation conditions vary sen-
sibly with the composition and sequence of the polypeptide,
single amino acid substitution has been used to investigate
the fibril formation (Chiti et al. 2002). In this study we
propose a formula to predict the change of aggregation and
disaggregation rate upon mutation. The agreement between
the experimental data and our formula leads us to the con-
clusion that the formation of fibrils can be explained with a
simple model based on physicochemical properties of
amino acids. We found that the polar and the nonpolar
water-accessible surface areas, the dipole moment, and the
-stacking interaction of aromatic residues (Gazit 2002) are
essential beside the charge and the -propensity of the se-
quence (Chiti et al. 2003). To have the most possible gen-
eral model, we do not use any parameter that needs to be
experimentally estimated. Furthermore, our equation does
not present any redundancy, whereas in previous work by
others charge and hydrophobicity were considered indepen-
dent and used as two different variables in the best-fitting
(Chiti et al. 2003).
We propose the following function to predict the effect of
a mutation on aggregation rate:
mutwt = hac (1)
where wt and mut are the aggregation rates of the wild type
and mutant, respectively. The factor h captures most of the
nonpolar and polar interactions. An amino acid is called p if
its side chain carries a charge or a dipole; otherwise it is
called a.
For mutations that involve same type of amino acids
a → a or p → p
h
I
= ASAmut
a
ASAwt
a
a → a
ASAwt
p
ASAmut
p
p → p
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where ASAa and ASAp are the nonpolar and polar water-
accessible surface areas of the amino acid side chains (Ma-
khatadze and Privalov 1990; Karplus 1997). Interestingly,
experimental evidence has been published recently on the
importance of nonpolar solvent-accessible surface area for
the amyloid-like properties of apomyoglobin (Chow et al.
2003).
For mutations that involve different types of amino acids
(a → p or p → a)
h
II
= 1Dmut a → pD
wt
p → a
where D is the magnitude of the dipole of the amino acid
side chains. The function Ih implies that the hydrophobicity
and aggregation rate increase as the mutation results in a
larger nonpolar surface or smaller polar surface. In IIh , it
has been assumed that the nonpolar surface of p amino acids
compensates the nonpolar surfaces of a amino acids so that
the dipole of p amino acids exclusively characterizes the
mutation (see Supplementary Table 1).
The factor  is related to the ratio of -sheet propensi-
ties (Street and Mayo 1999; see Supplementary Table 1):
 =
mut
wt
Functions a and c approximate the effect of the aromatic
residues A and total charge C, respectively:
ac = e
A
e
−|C|/2
The factor 1⁄2 before C has been introduced to have the same
range [−1, 1] for the arguments of the two exponential func-
tions.
In Figure 1 our model is used to predict the changes in
aggregation rates occurring in human muscle acylphospha-
tase (AcP), islet amyloid polypeptide, prion peptides,
-synuclein, amyloid -peptide, tau, leucine-rich repeat,
and some model peptides. As in Chiti et al. (2003), we
divided the data set in two parts to compare with their
equation. The correlation obtained with equation 1 is sig-
nificant (85% and 86% and P < 10−4), and slightly better
than the one obtained by Chiti et al. using three parameters
derived from best fitting (76% and 85% and P < 10−4). The
good agreement with experiments shows that our simple
equation, which does not contain any parameter, is very
general and can be used to describe the aggregation of sev-
eral and heterogeneous protein systems.
The validity of the formula is proved also by rearranging
the whole data set per a and p mutations: Slopes and cor-
relations are very close (see Supplementary Fig. 1; p → p:
slope  1.01, correlation  80%, number of points  28;
a → a: slope  0.92, correlation  82%, number of
points  15; a → p and p → a: slope  1.01, correla-
tion  89%, number of points  12).
Aggregation and disaggregation are intrinsically differ-
ent, but the role played by the hydrophobicity, -propensity,
-stacking, and charge is the same. Considering that disag-
gregation and aggregation are opposite processes, the direct
proportionality relation between mut/wt and hac that
describes the aggregation turns into a relation of inverse
proportionality for the disaggregation. Therefore, the recip-
rocal of equation 1 can be used to describe the disaggrega-
tion:
wtmut = hac (2)
To verify the validity of this assumption, we applied equa-
tion 2 to heptapeptide sequences suggested by a genetic
algorithm approach (G. Tartaglia and A. Caflisch, in prep.).
The genetic algorithm searches the space of sequences for
those that have the best match to a certain three-dimensional
target conformation (an in-register parallel aggregate of
three heptapeptides [Gsponer et al. 2003]). For each peptide
sequence, three replicas are submitted to a 330 K molecular
dynamics simulation, starting from the -parallel aggre-
gated conformation (CHARMM parameter 19 [Brooks et al.
1983] and solvent accessible surface-based solvation model
[Ferrara et al. 2002]). A temperature of 330 K is used to
obtain enough sampling in the time scale of the simulations
(Gsponer et al. 2003). Peptide sequences are ranked accord-
ing to their ability to prevent disaggregation. The disaggre-
gation rate is estimated for each sequence as the reciprocal
of the number of snapshots whose C root mean square
deviation (RMSD) from the template is lower than 1 Å. Best
Figure 1. Calculated vs. observed (Chiti et al. 2003) changes in aggrega-
tion rate upon mutation: AcP (28 triangles) and heterogeneous groups of
peptide and protein systems, including islet amyloid polypeptide, prion
peptides, -synuclein, amyloid -peptide, , leucine-rich repeat and some
model peptides (27 circles).
Tartaglia et al.
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matches, called best parents, are replicated and subjected to
mutations and crossover: 103 sequences have been studied
for a total amount of 50 sec of simulation. The genetic
algorithm predicted several sequences similar to segments
of amyloidogenic protein as well as the sequence
HFWLVFF, which presents five matches with the amyloid
-peptide fragment HQKLVFF (Tjernberg et al. 1999;
Williams et al. 2004). By considering that the genetic algo-
rithm sampled 103 sequences and a random search approxi-
mately needs 106 sequences to scan before finding five
matches, we conclude that the genetic algorithm approach
performs 103 better than random.
Disaggregation rates are analyzed with equation 2 only
for best parents (4% of data) for which false positives are
supposed to be less than the false negatives in the remaining
set. Furthermore, to have statistical significance, each dis-
aggregation rate has been averaged over a set of five mo-
lecular dynamics trajectories. Figure 2 shows that equation
2 holds and the correlation is very high (80% and P < 10−3).
In conclusion, the present results indicate that a simple
model based on physicochemical properties without param-
etrization is able to predict aggregation and disaggregation
rates.
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Abstract
The reliable identification of b-aggregating stretches in protein sequences is essential for the develop-
ment of therapeutic agents for Alzheimer’s and Parkinson’s diseases, as well as other pathological
conditions associated with protein deposition. Here, a model based on physicochemical properties
and computational design of b-aggregating peptide sequences is shown to be able to predict the
aggregation rate over a large set of natural polypeptide sequences. Furthermore, the model identifies
aggregation-prone fragments within proteins and predicts the parallel or anti-parallel b-sheet organiza-
tion in fibrils. The model recognizes different b-aggregating segments in mammalian and nonmamma-
lian prion proteins, providing insights into the species barrier for the transmission of the prion disease.
Keywords: Alzheimer’s disease; amyloid; protein aggregation rate; prion protein; species barrier;
genetic algorithm; molecular dynamics
Amyloid fibrils are associated with a number of pathol-
ogies including Alzheimer’s, Parkinson’s, Huntington’s,
prion disease, and type II diabetes (Horwich and Weiss-
man 1997; Kelly 1998; Dobson 1999; Rochet and Lans-
bury 2000). Therefore it is of fundamental medical
interest to understand the mechanisms of fibrillogenesis,
with the ultimate goal of designing inhibitors. One
important and still unanswered question regarding amy-
loid fibril formation is the specificity with which the
amino acid sequence determines b-aggregation propen-
sity and the atomic details of the fibril structure. Because
of the difficulties in obtaining detailed structural infor-
mation by X-ray crystallography or solution phase
NMR spectroscopy, computational approaches are
needed to guide experiments, e.g., to determine short
segments of amyloid-like proteins that share the same
biophysical properties of the full-length proteins (Balbir-
nie et al. 2001) and identify those elements which are
essential for the formation of protein fibrils (Tenidis et al.
2000; von Bergen et al. 2000). As aggregation condi-
tions vary sensibly with the composition and especially
the sequence of the polypeptide, single amino acid sub-
stitutions have been used to investigate the fibril forma-
tion (Chiti et al. 1999), and complementary theoretical
studies proposed relative rate equations to predict the
change of aggregation rate upon mutation (Chiti et al.
2003; Tartaglia et al. 2004). Although the application of
relative rate equations shows high correlation with experi-
mental data, these models require the a priori knowledge
of wild-type aggregation rates.
We report here an absolute rate equation derived from
both first principles and analysis of aggregating sequences
designed by a computational approach. The latter is based
on a genetic algorithm optimization in sequence space and
molecular dynamics sampling of conformation space. The
equation does not need any information except the amino
acid sequence and two environmental factors (i.e., tempera-
ture and concentration). Our model gives both the aggre-
gation rate and the ‘‘amyloid spectrum’’ of a protein,
identifying those segments involved in b-aggregation. In
Reprint requests to: Amedeo Caflisch, Department of Biochemistry,
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addition, the model distinguishes between the parallel and
anti-parallel b-sheet organization within the fibrils and
shows thatmammalian and nonmammalian prion proteins
have different amyloid spectra.
Results and Discussion
Absolute rate prediction
Predicted and experimentally measured rates are shown in
logarithmic scale in Figure 1. The correlation is 95% and
extends over 90 data points and about 15 natural logarith-
mic units. This is a remarkable result considering that the
rate is calculated solely from the primary structure with the
addition of two external factors, i.e., temperature and con-
centration. Interestingly, the correlation is good for differ-
ent proteins and also within mutants of the same protein.
For single-point mutants of long sequences (Acylphospha-
tase and Titin), the error is rather large because of the poor
signal-to-noise ratio due to the average over the entire
sequence. The model was subjected to statistical tests to
assess the chance correlation. In Figure 2A, the experimen-
tallymeasured rateswere randomlypermutated to generate
about 107 ‘‘scrambled’’ data sets. The calculated rates were
fitted to each scrambled set, giving an extremely small like-
lihood for high correlations. In Figure 2B, 107 data sets
were randomly generated within the range of experimental
rates. Thepredictive ability andcorrelationof themodel are
much higher than the corresponding values obtained upon
randomization of the experimental rates. These statistical
tests show that chance correlation is not present.
Prediction of b-aggregating segments
There is in vivo evidence that amyloid fibrils originate
from misfunctions of the degradation machinery and
cleavage of fragments that have high propensity for b-
aggregation (Stefani and Dobson 2003). Moreover, even
proteins not implicated in amyloid diseases were recently
found to form amyloid fibrils in vitro under denaturing
conditions, indicating that fibrillogenesis is a common
feature of proteins (Chiti et al. 1999; Dobson 1999; Ste-
fani and Dobson 2003). Our approach to estimate aggre-
gation rates can be also used to identify segments with
high aggregation propensity. The method is tested on the
following proteins: a-synuclein, apolipoprotein, amyloid
precursor protein (APP), gelsolin, islet amyloid precursor
protein (IAPP), lactadherin, prion, serum amyloid A,
transthyretin, ABri, ADan, fibrinogen, b2-microglobulin,
insulin, Sup35, and tau.The formernine proteins represent
all hits of a combined search for ‘‘amyloid’’ and ‘‘human’’
at http://www.expasy.org (Gasteiger et al. 2003) in Sep-
tember 2004; the latter seven proteins result from a litera-
ture search (references are reported in Table 1). As
indicated in Figure 3, the data set contains
 regions known to promote aggregation
 segments found to aggregate in vivo (often after degra-
dation)
 stretches extracted from the precursors and shown to
aggregate in vitro
Each sequence in the data set is scanned by shifting a
window of fixed size one residue at a time starting from the
N terminus. The extracted stretches are ranked using the
aggregation propensity p (see Materials and Methods).
The procedure is repeated for different window sizes (3–
25 amino acids), each time storing the positions of the three
stretches having the highest p. These positions are then
used to build the histogram of Figure 3. Peaks of the
histogram represent positions of stretches with the highest
b-aggregation propensity (‘‘windows’ consensus’’). All the
sequences except fibrinogen and prion showmain peaks in
segments known to promote aggregation. For prion, amy-
loidogenic areas are—up to now—not known and few
experiments have been performed and on limited portions
of the protein (Vanik et al. 2004). Following the protein-
only hypothesis (Prusiner 1988; Soto and Castilla 2004),
we suggest that the peak found at position 150 may be
determinant for prion transmissions (in the subsection
Prions, the same peak is numbered with 175 because of
the alignment with other prion sequences). For transthy-
retin, only one of the two experimentally known b-aggre-
gating fragments has been found with our analysis. We
speculate that the corresponding area promotes the aggre-
gation of the entire protein, which is consistent withNMR
data (Jaroniec et al. 2002).
Figure 1. Calculated (Equation 4; see Materials and Methods) vs.
observed aggregation rates for heterogeneous groups of peptide and
protein systems (Litvinovich et al. 1998; Konno et al. 1999; Chiti et al.
2003; Ferguson et al. 2003; DuBay et al. 2004). A t-student test on the
correlation shows the high significance in the prediction (in the present
study P<0.0001, while P^ 1 indicates no significance).
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To further test the sensitivity of ourmodel,we focusedon
the segments that are experimentally known to aggregate.
For this purpose, we used a window size of five consecutive
residues, as in a previous work (Fernandez Escamilla et al.
2004) (Table 1). Interestingly, several five-residue stretches
are found in segments that were shown to aggregate,
e.g., FGAIL contained in IAPP NFGAILSS, FILDL in
gelsolin’s SFNNGDCFILD, SVQFV in lacthaderin’s
NFGSVQFV, and YQQYN in Sup35’s PQGGYQQYN
(Azriel andGazit 2001). ForAPP, three stretches are found
in correspondence of the segment LVFFA, which is known
to be involved in the aggregation of Ab40 (Williams et al.
2004) (see subsection Amyloid Protein Precursor). Impor-
tantly, all the stretches are ranked among those having the
Table 1. Analysis of experimentally known b-aggregating segments
Protein 1st Stretcha Rankb 2nd Stretcha Rankb 3rd Stretcha Rankb Segment
Total
length Ref.
ABri 22{CSRTV}a 5 21{ICRST}a 8 20{LICSR}a 10 1–34 34 El-Agnaf et al. 2001
ADan 22{CFLNF}p 1 23{FNLFL}p 2 24{NLFLN}p 3 1–34 34 El-Agnaf et al. 2004
a-Synuclein 41{EQVTN}a 6 67[SIAAA]p 12 71[ATGFV]p 15 41–74 120 Ueda et al. 1993
Apolipoprotein A–I 18[YVDVL]p 1 28{DYVSQ}a 2 85[EMSKD]a 3 1–83 242 Nichols et al. 1988
APP 671{LVFFA}p 1 670{KLVFF}p 2 672{VFFAE}p 3 655–696 750 Weidemann et al. 1989
b-Microglobulin 61{SFYLL}p 1 63{TLLYY}p 2 66{YYTEF}p 3 59–79 99 Jones et al. 2003
Fibrinogen 494[FPGFF]p 7 493[TFPGF]p 13 482[AAFFD]p 32 482–504 623 Asl et al. 1997
Gelsolin 187{DCFIL}p 15 188{CFILD}p 23 189{FILDL}p 31 173–243 755 Kangas et al. 1996
IAPP 22{FGAIL}p 1 21{NFGAI}p 2 28[SNTYG]a 4 1–38 38 Westermark et al. 1987
Insulin 78{ENYCN}a 1 23{RGFFY}p 3 15{ALYLV}p 4 1–38 86 Jimenez et al. 2002
Lactadherin 260{YGNDQ}a 3 259{SYGND}a 4 289[SVQFV]p 5 245–294 364 Haggqvist et al. 1999
Prion 116{IIHFG}p 1 115{PIIHF}p 2 99[VVGGL]p 3 1–121 208 Vanik et al. 2004
Serum amyloid A 3{FFSFL}p 2 4{FSFLG}p 3 5{SFLGE}p 4 2–12 104 Westermark et al. 1992
Sup35 77[YQQYN]a 1 44[YQNYQ]a 2 67[YQQQY]a 3 1–112 683 King et al. 1997
Tau 621{SVQIV}p 23 632{SKVTS}a 24 627{KPVDL}p 25 617–636 757 Margittai and Langen 2004
Transthyretin 107[IAALL]p 1 114{YSYST}a 2 106[TIAAL]p 4 105–115 127 Jaroniec et al. 2002
aThe three five-residue stretches with the highest p, within the segments listed in the third to last column, are reported with the predicted parallel (p)
or anti-parallel (a) arrangement. The braces { } indicate stretches that are close to the peak found in the experimental regions using the windows’
consensus (Figure 3), while the brackets [ ] mark sequences that are distant from the peak. The integer before the brackets refers to the position of
the stretch in the processed protein (initial signal- and pro-peptides are omitted in the notation as in other works; see, for instance Kangas et al.
1996; Jones et al. 2003).
bThe rank of the stretches refers to the entire precursor protein and can in principle vary from 1 (i.e., the stretch has the highest p among all the
stretches in the precursor protein) to the total length of the precursor protein (i.e., the stretch has the lowest p among all the stretches in the
precursor protein).
Figure 2. Statistical tests to assess chance correlation. (A) Permutations of experimental rates: Probability distribution p of the
correlation coefficient r between rates calculated with Equation 4 (see Materials and Methods) and scrambled experimental
rates. The likelihood of obtaining high correlations (r>50%) with scrambled experimental rates is extremely small (p<1029).
(B) Randomization of experimental rates (within the same range of values): Cross-validated leave-one-out correlation coefficient
q=12PRESS/s2 (PRESS=predicted residual sum of squares, i.e., sum of squared differences between predicted and observed
values [Zoete et al. 2003]) vs. the correlation coefficient r. The predictive ability and correlation of the model (thick circle on the
top right) are significantly separated from the corresponding values obtained upon randomization of the experimental rates (thin
points). In both tests, 107 data sets were generated.
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highest p in the respective precursor proteins (see Table 1),
which suggests that a small window size is sufficient for the
identification of amyloidogenic regions. In Table 1, we also
list b-aggregating segments that have not yet been investi-
gated with experiments in vitro (e.g., YVDVL in apolipo-
protein A–I and ENYCN in insulin) and indicate the
predicted parallel or anti-parallel arrangement of the indi-
vidual segments in the fibril.
Amyloid protein precursor
Using a window size of five residues, the amyloid spectrum
of the 750-residue APP (Fig. 4) shows a predominant peak
at position 671 for the stretch LVFFA. Furthermore, the
predicted b-aggregating stretches AIIGL and IGLMV are
consistent with solid-state NMR (Antzutkin et al. 2002;
Bond et al. 2003) and scanning proline mutagenesis (Wil-
liams et al. 2004). The stretches with the highest rate for
eachwindow size in the range 3–25 are shown inTable 2 for
Ab42. Most of the high-aggregation stretches contain the
segment LVFFA and are parallel. As in experiments (Gor-
don et al. 2004), the segment KLVFFAE has a preferential
anti-parallel arrangement,whileAb42 is parallel (Antzutkin
et al. 2000; Torok et al. 2002). As shown in clinical reports
and oligomerization experiments performed with photo-
induced cross-linking of unmodified proteins (Bitan et al.
2003), we found that Ab42 has a higher aggregation pro-
pensity thanAb40 (ln pAb42=27, ln pAb40=29). Interest-
ingly, the experimental evidence indicates that the Ile41–
Ala42 extension of the 1–40 segment affects the rate of
amyloid formation rather than the fibril stability (Jarrett
et al. 1993).
Prions
To further investigate the usefulness of our model, the
amyloidogenic propensities of the prion protein from dif-
ferent organisms were evaluated using a moving window
of five residues along the entire sequence. To compare the
amyloid spectra, prion sequences have been aligned using
ClustalW (Thompson et al. 1994). It is remarkable that
prion sequences in mammals show a peak at position 175
corresponding to the segment SNQNN in human prion
(Fig. 5; Table 3; all the notations used to number stretches
refer to the major prion proteins, i.e., signal- and/or pro-
peptides are omitted). Such a peak is absent in the chicken
and the turtle. Interestingly, the peak is located in a glu-
tamine/asparagine-rich region, which shows high propen-
sity to self-propagate in amyloid fibrils (Michelitsch and
Weissman 2000). Other peaks correspond to b-strand 2
(segment NQVYY, conserved in mammals and nonmam-
mals and mutated in NRVYY in chicken) and helix 1 of
Figure 3. Windows’ consensus. Different window sizes (3–25 amino acids) are used to scan proteins. Positions of stretches with
highest aggregation propensity p are used to build the histogram. Except for fibrinogen and prion, the highest peak is located in
segments that are known to form amyloid fibrils and/or contribute to protein aggregation (gray regions). The letter ‘‘p’’ labels
regions that are known to promote fibrillogenesis (‘‘p’’ standing for ‘‘promoting’’). The letter ‘‘f ’’ indicates segments that are
found to aggregate in vivo (‘‘f ’’ standing for ‘‘fragment’’) after degradation. The letter ‘‘e’’ refers to stretches that are shown to
aggregate in vitro (‘‘e’’ standing for ‘‘extracted’’). We stress that Equation 1 (see Materials and Methods) was used to identify b-
aggregating stretches and not to predict amino acid deletions or insertions involved in amyloidosis. Positions refer to proteins
without signal- and pro-peptides. References for all the experiments are reported in Table 1.
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human prion (segment YEDRY in mammals, WNENS in
turtle, and WSENS in chicken), which are known to form
ordered aggregates in vitro (Nguyen et al. 1995; Kozin et al.
2001). Furthermore, the amyloid profiles are similar within
mammals (e.g., 97% correlation between man and cow)
and different between mammals and nonmammals
(e.g., 55% correlation between man and turtle).
To comparewith experiments in vitro (Vanik et al. 2004),
we analyzed the unstructured region of the prion protein
(residues 1–122) in human, mouse, and hamster prion pep-
tides.We found thathumanandmouse prions share similar
amyloid spectra (i.e., 98% correlation), while the hamster
prion diverges from them at position 143 (position 116 in
the nonaligned human sequence). More specifically, the
stretch 143–148 of hamster prion (position 116–121 in the
nonaligned human sequence) is found to be less amyloido-
genic than the corresponding segment inmouse and human
(ln phamster=216, ln pmouse=212, and ln phuman=212),
which is consistent with the prion 1–122 species barrier
observed in vitro (Vanik et al. 2004).
Huntingtin
The gene for Huntington’s disease consists of 67 hexons
and contains an open reading frame for a polypeptide of
>3140 residues. Using a window size of five residues,
our model identifies the N-terminal poly(Gln) repeat
and the stretch IFFFL in the middle of the sequence as
the two most prone to induce ordered aggregates. With
window sizes larger than 20, the N-terminal poly(Gln)
repeat dominates and the peak in the middle of the
sequence disappears.
Our model is not sensitive enough to discriminate
repeats of fewer than 38 glutamine residues from those
with >41 glutamine residues; the former are harmless,
whereas the latter are responsible for toxic aggregates
(Perutz et al. 1994; Perutz 1999). Alternatively, the dra-
matic difference in toxicity observed at a repeat length of
40 might require the context of a much longer poly-
peptide sequence.
Conclusions
Themodel presented herewasmotivated by the challenging
tasks of predicting aggregation propensity and identifying
b-aggregating stretches inpolypeptide sequences.Anessen-
tial element in the derivation of the equation was the anal-
ysis of a large pool of b-aggregating peptide sequences
designed by a computational approach based onmolecular
dynamics and genetic algorithm optimization in sequence
space (G.G. Tartaglia and A. Caflisch, in prep.). The very
Figure 4. Amyloid protein precursor. The aggregation propensity p is
averaged over a window of five amino acids. The entire sequence is
scanned by shifting the window by one residue at a time starting from
the N terminus (‘‘amyloid spectrum’’). The analysis shows a major
peak corresponding to the segment LVFFA at position 671. The
bottom plot focuses on the most amyloidogenic region, which is high-
lighted in gray in the top plot. Windows of different sizes (5, 7, and 10
amino acids), shifted to the central amino acid, give similar results,
indicating the robustness of the model. Furthermore, with longer win-
dow sizes, peaks in the C terminus of Ab40 become comparable to the
one at position 671 (see also Table 2). In both plots, the effective height
of the peak is compressed by the logarithm scale.
Table 2. Stretches of Ab42 with the highest rate at each
window size in the range 3–25
Sequence ln p p/a
VFF {IGL} 5.3 {22.6} p
LVFF {GAII} 2.5 {26.7} p
LVFFA {AIIGL} 0.2 {27.5} p
LVFFAE {GAIIGL} 23.9 {28.0} p
KLVFFAE {AIIGLMV} 25.9 {210.0} a
LVFFAEDV {IGLMVGGM} 27.3 {210.1} p
LVFFAEDVG {GLMVGGVVI} 27.6 {210.0} p
QKLVFFAEDV {IGLMVGGVVI} 29.3 {29.7} a
{QKLVFFAEDVG} IGLMVGGVVIA 210.1 {211.0} p
{HQKLVFFAEDVG} AIIGLMVGGVVI 210.5 {211.1} p
{FFAEDV . . . } GAIIGLMVGGVVI 210.5 {210.7} p
FFAEDVGSNKGAII 210.1 p
VFFAEDVGSNKGAII 29.3 p
VFFAEDVGSNKGAIIG 29.7 p
LVFFAEDVGSNKGAIIG 28.8 p
LVFFAEDVGSNKGAIIGL 28.2 p
KLVFFAEDVGSNKGAIIGL 29.3 p
KLVFFAEDVGSNKGAIIGLM 29.4 p
QKLVFFAEDVGSNKGAIIGLM 210.5 p
QKLVFFAEDVGSNKGAIIGLMV 210.1 p
LVFFAEDVGSNKGAIIGLMVGGV 210.7 p
LVFFAEDVGSNKGAIIGLMVGGVV 210.4 p
LVFFAEDVGSNKGAIIGLMVGGVVI 27.1 p
In braces are reported stretches that ranked after the highest rate ones
and do not overlap with them. The last column contains the preferred
b-sheet arrangement, i.e., parallel (p) or anti-parallel (a).
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good correlationbetweencalculatedand experimental rates
for a large and heterogeneous set of polypeptide chains has
allowed us to use the model to successfully identify b-
aggregating segments and predict the parallel or anti-par-
allel arrangement. Fibrils formed by short segments of a
protein might have a different molecular structure than the
fibril of the full-length protein. Yet our results, as well as
previous experimental (Chiti et al. 1999, 2003; Balbirnie et
al. 2001) and computational (Fernandez Escamilla et al.
2004) works by others, indicate that the amyloid-forming
part of a protein could be only a short segment of the entire
chain. That a function based on simple physicochemical
principles is able to predict aggregation rates and identifyb-
aggregating fragments in proteins might be a consequence
of the essential role of side-chain interactions in b-sheet
aggregates (Gazit 2002; Gsponer et al. 2003; Linding et al.
2004).
Although some of the physicochemical properties in our
model are similar to those used in previous works by others,
it is important to distinguish approaches based on param-
eter optimization for a multiterm equation (Chiti et al.
2003; DuBay et al. 2004) from first-principle models like
the one of this work and that of Tartaglia et al. (2004). On a
very similar test set of peptides and proteins, the multi-
parameter approach gives results comparable to those
obtained with our model, but it is likely to have a lower
predictive ability. As an example, positional effects are
taken into account in ourmodel, whereas they are neglected
in the multiparameter approach (DuBay et al. 2004), which
is mainly based on amino acid composition and alternation
of hydrophobic–hydrophilic residues (Broome and Hecht
2000). Recent scanning prolinemutagenesis, combinedwith
critical concentration analysis and NMR hydrogen–deu-
Figure 5. Prion proteins from turtle to human. The plot shows an evolutionary differentiation of the aggregation peaks. Prions
of cow and mouse, as well as prions of sheep and pig, show similar amyloid spectra (data not shown). The highest peak at
position 175 for mammals (segment a, i.e., SNQNN) is not present in nonmammals. Peak b (segment NQVYY, conserved in
mammals and nonmammals, and mutated to NRVYY in chicken) appears in correspondence of b-strand 2 in human prion.
Nonmammals show a peak c (segment WNENS in turtle and WSENS in chicken) in correspondence of the first helix of human
prion that is weaker in mammals (YEDRY). Sequences have been aligned using ClustalW (Thompson et al. 1994) at http://
www.expasy.org/cgi-bin/hub (Gasteiger et al. 2003). Horizontal traits in the plots represent gaps and are meant to help the eye.
For all the species, no significant peak is found in the N-terminal tandem repeats. The secondary structural elements of the
human prion are labeled with Greek letters and the stretches corresponding to the three a-helices are emphasized by shadowed
rectangles.
Table 3. Peak at position 175. Prion compatibilies of
animals with respect to human
Animal Dp/p
Turtle 9.52
Chicken 8.72
Sheep 1.66
Pig 1.13
Cow 0.76
Mouse 0.76
Hamster 0.15
The distance with respect to the human prion sequence is measured as
Dp/p ¼ (panimal – phuman)/phuman using a window size of five amino
acids for the rate calculation and summing over the segment 165–185
to better sample the variability around the peak.
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terium exchange, indicate a strong positional effect on both
the aggregation kinetics and structural properties of the
Ab40 fibril (Williams et al. 2004). Most importantly, the
multiparameter approach cannot be used to identify b-
aggregating segments as explicitly mentioned by the inves-
tigators (DuBay et al. 2004).
Recently, an approach based on secondary struc-
ture propensity and estimation of desolvation penalty
(TANGO) has been shown to accurately predict the
sequence-dependent and mutational effects on the aggre-
gation of a large data set of peptides and proteins (Fer-
nandez Escamilla et al. 2004). TANGO is based on the
assumption that the probability of finding >2 ordered
segments in the same polypeptide is negligible. The
investigators report that TANGO allows quantitative
comparison within the same polypeptide chain or
mutants. On the other hand, only qualitative compari-
son between different polypeptide chains is possible with
TANGO (Fernandez Escamilla et al. 2004), whereas our
model allows for the prediction of absolute rates (Fig. 1).
In conclusion, we have identified the physicochemical
properties of amino acids that are essential for ordered
aggregation and proposed a model that takes into account
sequence effects for aromatic and charged residues, as well
as composition. Compared with the models previously
published by others, our equation is the only one that
takes explicitly into account p-stacking. Very recent high-
resolution structural data (electron and X-ray diffraction)
have provided strong evidence for the importance of aro-
matic side chains for amyloid formation (Makin et al.
2005).
Our model derived from first principles and analysis
of in silico designed sequences is able to predict aggrega-
tion rates and identify b-aggregating segments with high
accuracy, suggesting possible biological implications as
in the prion protein case. For nonmammalian prions, the
absence of the peak at position 175 observed in mam-
mals decreases the overall aggregation propensity, in-
dicating a species-specific behavior consistent with
experiments (Marcotte and Eisenberg 1999; Matthews
and Cooke 2003) and supporting the hypothesis of a
species barrier in the transmission of the prion disease
(Hill et al. 2000).
In the accompanying article we present a bioinfor-
matics application of our model that reveals an anti-
correlation between organism complexity and proteomic
b-aggregation propensity (Tartaglia et al. 2005).
Materials and methods
Absolute rate equation
An equation based on physicochemical properties of natural
amino acids is introduced to estimate the aggregation rate of
proteins and identify b-aggregating segments. Aromaticity, b-
propensity, and formal charges play a major role in our model,
as they are known in the literature to be determinant for
fibrillization (Gazit 2002; Tjernberg et al. 2002; Chiti et al.
2003). Polar and nonpolar surfaces, as well as solubility, are
also taken into account following an analysis of sequences
designed to aggregate into b-sheets. The design of b-aggregat-
ing sequences was performed by structural sampling using
molecular dynamics and peptide sequence optimization by a
genetic algorithm (Tartaglia et al. 2004; G.G. Tartaglia and A.
Caflisch, in prep.) (see subsection Derivation of the Equation).
The aggregation propensity pil of an l-residue segment starting
at position i in the sequence is evaluated as:
il ¼ ilil ð1Þ
The factor Fil contains exponential functions and is position-
dependent
il ¼ e
AilþBilþCil ð2Þ
where Ail, Bil, and Cil are functionals related to the aromatic-
ity, b-propensity, and charge, respectively. The factor il
depends almost exclusively on the amino acid composition
il ¼
Yiþl1
j¼i
Saj
S^a
"" þ
S
p
j
S^p
"#
 
S^t
Stj
^
j
" #1=l
ð3Þ
where Sai , S
p
i , S
t
i, and si—weighted by their average over the
20 standard amino acids (hatted values)—are the side-chain
apolar, polar, total water-accessible surface area, and solubil-
ity, respectively (see subsection Parallel and Anti-Parallel
Configuration). The functionals y"" and y"# include positional
effects and reflect the parallel or anti-parallel tendency to
aggregate if the majority of residues is apolar or polar, respec-
tively. Considering the high correlation between measured and
predicted changes in aggregation rate upon single point muta-
tions (Chiti et al. 2003; DuBay et al. 2004; Tartaglia et al.
2004), it is possible to utilize the propensity pil to predict the
absolute rate nil
il ¼  c;Tð Þ il ð4Þ
where a(c,T) is introduced to take into account concentration
and temperature (see subsection Concentration and Tempera-
ture).
Parallel and anti-parallel configuration
The functional for the parallel or anti-parallel configuration
was introduced following the analysis of sequences designed by
genetic algorithm optimization (see subsection Derivation of
the Equation; Fig. 6):
 The parallel in-register b-sheet organization within fibrils is
favored by the number of side chains involved in p-stacking
(Tyr, Phe, and Trp) and apolar interactions (Ala, Gly, Ile,
Leu, Met, Pro, and Val) (McGaughey et al. 1998; Azriel and
Gazit 2001; Jenkins and Pickersgill 2001; Makin et al.
2005). The number of aromatic and apolar residues is indi-
cated with naromatic and napolar, respectively. Hydrogen bonds
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between polar residues are not considered for the parallel
aggregation because the number of polar residues decreases
significantly during the optimization of parallel aggregated
sequences (Fig. 6).
 The anti-parallel configuration is mainly determined by the
electric dipole moment of the polypeptide (Hwang et al.
2004). Sequences abounding in polar residues show a small
tendency for the parallel in-register aggregation because of
unfavorable dipole–dipole interactions between side
chains. Hence, the anti-parallel organization is promoted
by the number of polar residues (Arg, Asn, Asp, Cys, Gln,
Glu, His, Lys, Ser, and Thr), which is indicated with npolar.
In some specific positions, charged (Arg, Lys, Asp, and
Glu) and aromatic amino acids contribute to the anti-par-
allel aggregation. ‘‘Specific positions’’ means that one or
more couples of opposite charged residues or one or more
aromatic residues are symmetrically placed with respect to
the center of the sequence (Balbach et al. 2000; Hwang
et al. 2004; Makin et al. 2005). In this specific case, the
number of charged and aromatic residues is labeled as
nscharge and n
s
aromatic, respectively.
In Equation 3, a parallel configuration is preferred if
napolar+ naromatic> npolar+ n
s
charge+ n
s
aromatic. Since the
number of aromatic residues in symmetric position is always
smaller than the total amount of aromatic residues,
naromatic n
s
aromatic (e.g., in the APP stretch: LVFFA
naromatic=2, n
s
aromatic=1), we used a stricter condition for the
parallel arrangement napolar> npolar+ n
s
charge. The stricter con-
dition allows the factorization of aromatic contributions in
Equation 1. In the il factor of Equation 3, y
"" and y"# are
"" ¼
1 napolar  npolar þ n
s
charge
0 otherwise

"# ¼ 1 ""
It is useful to explain the effect of the y"" and y"# functional by
some examples. The segment LVFFA at position 671–676 of
the APP is predicted to be parallel because it satisfies the
parallel condition napolar> npolar+ n
s
charge with napolar=3 and
npolar= n
s
charge=0 (y
""=1). The segment KLVFFAE (at posi-
tion 670–677 of the APP), with two opposite charged residues,
has anti-parallel propensity because it satisfies the anti-paral-
lel condition napolar< npolar+ n
s
charge with napolar=3 and
npolar = n
s
charge=2 (y
"#=1).
The IAPP stretch FGAIL at position 22–26 is predicted to
be parallel (napolar=4 and npolar= n
s
charge=0, i.e.,y
""=1), in
agreement with experimental results (Kayed et al. 1999a;
Azriel and Gazit 2001; Gazit 2002). As in Azriel and Gazit
(2001), the following stretches are predicted to be parallel:
SVQFV at position 289–292 of lactadherin; DCFIL, CFILD,
Figure 6. Computational design: A genetic algorithm approach was developed to search the space of peptide sequences for those
with the best match to a given three-dimensional target conformation, i.e., an in-register parallel or anti-parallel aggregate of
three heptapeptides (Gsponer et al. 2003). For each peptide sequence, three replicas were submitted to a 330 K molecular
dynamics simulation, starting from the b-aggregated conformation using CHARMM parameter 19 and a solvent-accessible
surface-based solvation model (Brooks et al. 1983; Ferrara et al. 2002). The sequence optimization was performed by evolu-
tionary cycles. A total of 1728 sequences was sampled after 18 cycles. In sequences selected for the parallel aggregation, the
number of aliphatic and aromatic residues increases almost monotonically, while the number of charged and polar residues
decreases. The opposite is observed in sequences selected for the anti-parallel aggregation. In the plots, the number of aliphatic,
aromatic, charged, and polar residues is normalized by the length of the peptide and averaged over the population (48 peptides
per cycle).
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and FILDL at position 187–191, 188–192, and 189–193 of
gelsolin, respectively; FFSFL, FSFLG, and SFLGE at posi-
tion 3–7, 4–8, and 5–9 of serum amyloid, respectively.
Poly(Gln), poly(Asn), and poly(Lys) homopolymers are pre-
dicted to be in an anti-parallel arrangement, as proposed in
Perutz et al. (1994), Scherzinger et al. (1997), and Michelitsch
andWeissman (2000) and observed by Tanaka et al. (2001) and
Dzwolak et al. (2004). Moreover, it is likely that completely
aliphatic sequences result in amorphous aggregates if N and C
termini are capped, while a tendency to the anti-parallel
arrangement is expected for short stretches with charged ter-
mini (e.g., transthyretin’s stretch IAALL). Capping groups are
neglected in the present version of the model.
The fragment GNNQQNY from the Sup35 yeast prion is
predicted to be anti-parallel (napolar=1, npolar=5, and
nscharge=0, i.e.,y
"#=1), in contrast with the parallel packing
suggested on the basis of X-ray diffraction and Fourier trans-
form infrared (FTIR) data (Balbirnie et al. 2001). On one
hand, it is important to note that the experimental data sup-
porting a parallel arrangement are not conclusive, and, in
particular, FTIR can be misleading on this point. In fact, in
the unit cell of the microcrystals, the parallel b-sheets are
proposed to be in anti-parallel contact along the fibril axis.
On the other hand, a possible reason for the parallel config-
uration is that the p-interactions between the Tyr side chains
are much less favorable in the anti-parallel configuration.
Aromatic residues
Aromatic side chains contribute to the parallel aggregation
with p-interactions (McGaughey et al. 1998; Azriel and Gazit
2001; Makin et al. 2005). The density of aromatic residues
naromatic/l is used to distinguish two regimes for the aromatic
contribution Ail of Equation 2:
Ail ¼
Alowil naromatic=l  3=20
A
high
il otherwise

where 3/20 is the aromatic density averaged over the 20 stan-
dard amino acids and naromatic was defined in the previous
subsection. In the case of low aromatic density (naromatic/l3/20),
Ail
low takes into account the polar/apolar environment. Following
the results obtained by the genetic algorithm optimization of b-
aggregation-prone sequences (see Fig. 6), Ail
low has a positive
effect for mainly apolar sequences and a negative contribution
for mainly polar sequences:
Ail
low= naromatic [napolar2 (npolar+ n
s
charge)] l
21
The variables napolar, npolar, and n
s
charge are defined in the pre-
vious subsection.
As an example, the APP stretch LVFFAEDVGSNK-
GAIIGLMVGGVVI shows low aromatic density (naromatic/
l=2/25<3/20). Since i=671, l=25, napolar=17, npolar=6,
and nscharge=0, the aromatic contribution for LVFFAED-
VGSNKGAIIGLMVGGVVI is Alow671 25=2 [172 6] 25
21=
0.88.
In the case of a high aromatic density (naromatic/l>3/20), the
model takes into account the number of aromatic residues:
Ail
high = naromatic
As an example, the APP stretch LVFFA shows high aro-
matic density (naromatic/l=2/5>3/20). Since i=671 and
l=5, the aromatic contribution for LVFFA is Ahigh671 5=2.
Besides the total amount of aromatic residues and the posi-
tion dependence, which enters Equation 2 through Ail
low, the
different polar and apolar side-chain surfaces, solubility, and
b-propensity of Phe, Tyr, and Trp are taken into account in the
factor il. Hence, the mutation F22Y for the IAPP (islet b-
amyloid protein precursor) stretch NFGAILSS produces a
sensible change of rate (ln pwt=26,ln pF22Y=27), compati-
ble with experiments in vitro (Porat et al. 2003).
b-Propensity
The b-propensity is evaluated as the fraction of residues that
stabilize the b-sheet more than the a-helix:
Bil=bil l
21
2 1/2
The function bil is defined as:
il ¼
Xiþl1
j¼i
j
where
j ¼
1 j  j
0 otherwise

The variables aj and bj correspond to the a-helix and b-sheet
stabilizing effects of the amino acid at position j (Fersht 1999).
Values of aj and bj are normalized from 0 (low stabilization) to
1 (high stabilization) to have the same range of variability. In
the function Bil, the offset value of 1/2 is introduced so that
Bil>0 if at least one-half of the residues in the sequence is
more stable in a b-sheet rather than in an a-helix conformation
(i.e., bil> l
21/2).
In the case of the APP stretch LVFFA, values are i=671,
l=5, b672= b673= b674=1, and b671= b675=0. The pre-
dicted b-propensity for LVFFA is b671 5=3/52 1/2=0.1.
Charged residues
As in other models, we consider that the electrostatic repulsion
of charged sequences penalizes the aggregation (Chiti et al.
2003; Tartaglia et al. 2004). In addition, our model takes into
account the fact that side-chain pairs with opposite charges
and positioned symmetrically with respect to the center of the
segment contribute to the anti-parallel aggregation, as found in
experiments (Gordon et al. 2004). In Equation 2, the charge
contribution Cil is
Cil ¼ 
ncharge
l
j
Xiþl1
j¼i
Cj j þ
Xiþl1
j¼i
chargej
where Cj is the charge of the side chain and ncharge is the
number of charged residues. The first term of the functional
Cil takes into account the electrostatic repulsion between poly-
peptides with net charge different from zero. The second term
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counts the number of pairs of opposite charged side chains
that are symmetrically placed with respect to the central resi-
due of the sequence:
chargej ¼
1 Cj ¼ C2iþlj1 and Cj 6¼ 0
0 otherwise

In the case of the APP stretch KLVFFAE, the residues K670
and E676 have opposite charges and are symmetrically placed
with respect to the central amino acid F673. Since i=670,
l=7, C670=+1, and C1340+72 6702 1=C676=21, the net
charge for KLVFFAE is j
P
iþl1
j¼i Cj j ¼ 0 and the oppositely
charged K670 and E676 give C670 7= d670
charge+ d676
charge=2.
Surfaces and solubility
For sequences that are predominantly apolar (y""=1; see
subsection Parallel and Anti-Parallel Configuration), the apo-
lar water-accessible surface Saj measures the contribution of
hydrophobic side chains to aggregation. For mostly polar
sequences (y"#=1), the polar water-accessible surface Spj
takes into account the propensity to form hydrogen bonds
between polar residues. The total surface Stj= S
a
j + S
p
j is
used to weight polar and apolar surfaces by the total area.
Values of apolar and polar side-chain surfaces are given in
our previous work (Tartaglia et al. 2004) and span the intervals
44 –195 A˚2 and 27–107 A˚2, respectively. Averaged values are
Sˆa=108 A˚2 and Sˆp=54 A˚2. In the case of poly(Gln), values of
surfaces are Sa=53 A˚2 and Sp=91 A˚2. Since Gln is polar and
y"#=1, the surface contribution is Sp/Sˆp  Sˆt/St=(91/54)(162/
144)=1.9.
The variable sj takes into account the water solubility of the
side chain at position j. In our model, aggregation propensity
and solubility are inversely proportional to introduce a penalty
for highly soluble polypeptides. Most of the solubility values
are available at http://acrux.igh.cnrs.fr/proteomics/densities_
pi.html (Nahway 1989). The missing values (Cys, Lys, and
Thr) were taken from http://www.formedium.com/Europe/
amino_acids_and_vitamins.htm. The variable sj spans the
interval 0.04–162 g/100 g, with average sˆ=3.95 g/100 g. In
the case of poly(Gln), sˆ/s=3.95/2.5=1.5, which indicates
low solubility in agreement with experiments of b-aggregation
(Perutz et al. 1994; Perutz 1999).
Concentration and temperature
The function a(c,T ) captures the effects of concentration (c)
and temperature (T) in Equation 4:
 c;Tð Þ ¼ RT
c c 2 0; c½  mM
1 c 2 c; 1ð mM
1=c c > 1 mM
8<
:
The aggregation rate n is approximated to be proportional to
the temperature because the probability of collision and elon-
gation of peptides increases with temperature (Kusumoto et al.
1998). Although aggregation rate and temperature are not
expected to correlate above physiological values (Massi and
Straub 2001), we used a simple linear dependence, which is
preferable for the small extent of experimentally accessible
values of the temperature. In fact, the temperature ranges
from 298 K to 310 K in the data set of Figure 1.
In agreement with quasielastic light-scattering experiments
of fibrillogenesis of Ab40, the aggregation rate n is assumed to
be proportional to the concentration for c< c* mM (c*=0.1
mM) and to be independent of concentration above the critical
value c= c* (Lomakin et al. 1996, 1997) (see also subsection-
Derivation of the Equation). The hyperbolic function 1/c was
introduced to decrease the aggregation rate n for c>1 mM, as
there is experimental evidence that a very high concentration
opposes formation of ordered aggregates (Munishkina et al.
2004). The concentration ranges from 0.01 mM to 20 mM in
the data set of Figure 1.
Derivation of the equation
 Functionals for aromaticity, b-propensity, and charge were
taken from our relative rate equation (Tartaglia et al. 2004).
The aromatic term was modified according to the results
obtained by the genetic algorithm optimization of aggregating
sequences (Fig. 6) (G.G. Tartaglia and A. Caflisch, in prep.).
The functional for b-propensity, previously based on a single
scale (Tartaglia et al. 2004), now takes into account b- versus
a-propensity. Scales for b- and a-propensity are taken from
Fersht (1999) and normalized in the range 0–1. The term used
for the b-propensity was tested on 100 globular proteins: 82%
of the b-sheet content is successfully recognized (data not
shown). The functional for charged residues was modified
with the addition of a term for symmetrically placed charges
of opposite signs, which is consistent with experimental data
(Gordon et al. 2004). The function ncharge/l replaces the con-
stant factor in the relative rate (Tartaglia et al. 2004) and is
introduced to weight the overall charge by the charge density.
The three functionals for aromaticity, charge, and b-propen-
sity can be zero. Exponential functions were introduced so
that their product is different from zero.
 The product of the three functionals was plotted versus
available experimental rates (see next subsection), obtaining
a correlation of 80%, while the individual correlations for
aromaticity, charge, and b-propensity are 76%, 81%, and
70%, respectively.
 The dependence on concentration and temperature was intro-
duced toderive aggregation rates frompropensities (Lomakin et
al. 1997;Kusumoto et al. 1998;Massi andStraub2001;Munish-
kina et al. 2004). With the concentration alone, the correlation
improves to 85%. The correlation is 82% without the hyper-
bolic function for high concentrations (c>1 mM). With the
temperature function, the correlation improves to 88%.
 The factor for polar/apolar contributions fil in Equation 1
was added upon the analysis of sequences produced by
computational design (Fig. 6). The term is a linear combina-
tion of normalized surfaces and has a nonzero minimum.
The correlation improves to 92%. The solubility dependence
was added at the very end and introduces a penalty for
highly soluble sequences. The correlation improves to 95%.
Experimental data
Most of the experimental rates were kindly provided by Dr. F.
Chiti and Dr. M. Vendruscolo (Chiti et al. 2003; DuBay et al.
2004). The remainder data set was taken from previous experi-
mental studies (Litvinovich et al. 1998; Konno et al. 1999;
Ferguson et al. 2003). The absolute aggregation rates were
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determined from in vitro experiments of denaturated polypep-
tide chains without taking into account the presence of cellular
components as chaperones and proteases. Aggregation rates
were obtained from kinetic traces in different ways: thioflavin
T fluorescence, turbidity, CD, sedimentation, size exclusion
chromatography, and filtration. Lag phases were not consid-
ered in the analysis, as they were not reported or difficult to
extract from published data (DuBay et al. 2004). Since a
comprehensive understanding of lag phases in protein aggrega-
tion is lacking (Kayed et al. 1999b; Padrick and Miranker
2002) (e.g., it is not known whether fibrils form by addition
of monomers or oligomers and how growth conditions influ-
ence the amyloid formation), the aggregation kinetics was
analyzed after the lag phase. The elongation phase showing
an exponential behavior is fitted to the function z=a
(12 e2nt) where n is the rate measured in sec21.
Acknowledgments
We thank Prof. C. Dobson, Prof. F. Chiti, Dr. M. Vendrus-
colo, and Dr. J. Zurdo for providing rates of several proteins.
The molecular dynamics simulations were performed on the
Matterhorn Beowulf cluster at the Informatikdienste at the
University of Zurich. We thank C. Bolliger, Dr. T. Steenbock,
and Dr. A. Godknecht for setting up and maintaining the
cluster. This work was supported by the Swiss National Science
Foundation and the NCCR ‘‘Neural Plasticity and Repair.’’
The program for the calculation of aggregation rates is
available from the corresponding author upon request.
References
Antzutkin, O.N., Balbach, J.J., Leapman, R.D., Rizzo, N.W., Reed, J.,
and Tycko, R. 2000. Multiple quantum solid-state NMR indicates a
parallel, not antiparallel, organization of b-sheets in Alzheimer’s b-
amyloid fibrils. Proc. Natl. Acad. Sci. 97: 13045–13050.
Antzutkin, O.N., Leapman, R.D., Balbach, J.J., and Tycko, R. 2002.
Supramolecular structural constraints on Alzheimer’s-amyloid fibrils
from electron microscopy and solid-state nuclear magnetic resonance.
Biochemistry 41: 15436–15450.
Asl, L.H., Liepnieks, J.J., Uemichi, T., Rebibou, J.M., Justrabo, E.,
Droz, D., Mousson, J.M.C., Benson, M.D., Delpech, M., and
Grateau, G. 1997. Renal amyloidosis with a frame shift mutation
in fibrinogen a-chain gene producing a novel amyloid protein.
Blood 90: 4799–4805.
Azriel, R. and Gazit, E. 2001. Analysis of the minimal amyloid-forming frag-
ment of the Islet amyloid polypeptide. J. Biol. Chem. 276: 34156–34161.
Balbach, J.J., Ishii, Y., Antzutkin, O.N., Leapman, R.D., Rizzo, N.W., Dyda,
F., Reed, J., and Tycko, R. 2000. Amyloid fibril formation by a b16–22, a
seven-residue fragment of the Alzheimer’s b-amyloid peptide, and struc-
tural characterization by solid state NMR. Biochemistry 39: 13748–13759.
Balbirnie, M., Grothe, R., and Eisenberg, D. 2001. An amyloid-forming
peptide from the yeast prion Sup35 reveals a dehydrated b-sheet struc-
ture for amyloid. Proc. Natl. Acad. Sci. 98: 2375–2380.
Bitan, G., Kirkitadze, M.D., Lomakin, A., Vollers, S.S., Benedek, G.B.,
and Teplow, B.D. 2003. Amyloid Ab-protein Ab assembly: Ab40 and
Ab42 oligomerize through distinct pathways. Proc. Natl. Acad. Sci.
100: 330–335.
Bond, J.P., Deverin, S.P., Inouye, H., El-Agnaf, O.M.A, Teeter, M.M.,
and Kirschnera, D.A. 2003. Assemblies of Alzheimer’s peptides Ab25–
35 and Ab31–35: Reverse-turn conformation and side-chain interac-
tions revealed by x-ray diffraction. J. Struct. Biol. 141: 156–170.
Brooks, B.R., Bruccoleri, R.E., Olafson, B.D., States, D.J., Swaminathan, S.,
andKarplus,M. 1983.CHARMM:Aprogram formacromolecular energy,
minimization, and dynamics calculations. J. Comput. Chem. 4: 187–217.
Broome, B.M. and Hecht, M.H. 2000. Nature disfavors sequences of
alternating polar and non-polar amino acids: Implications for
amyloidogenesis. J. Mol. Biol. 296: 961–968.
Chiti, F., Calamai, M., Taddei, N., Stefani, M., Ramponi, G., and Dob-
son, C.M. 1999. Studies of the aggregation of mutant proteins in vitro
provide insights into the genetics of amyloid diseases. Proc. Natl. Acad.
Sci. 99: 16419–16426.
Chiti, F., Stefani, M., Taddei, N., Ramponi, G., and Dobson, C.M. 2003.
Rationalization of the effects of mutations on peptide and protein
aggregation rates. Nature 424: 805–808.
Dobson, C.M. 1999. Protein misfolding, evolution and disease. Trends
Biochem. Sci. 24: 329–332.
DuBay, K.F., Pawar, A.P., Chiti, F., Zurdo, J., Dobson, C.M., and Ven-
druscolo, M. 2004. Predicting absolute aggregation rates of amyloido-
genic polypeptide chains. J. Mol. Biol. 341: 1317–1326.
Dzwolak, W., Muraki, T., Kato, M., and Taniguchi, Y. 2004. Chain-length
dependence of a-helix to b-sheet transition in polylysine: Model of
protein aggregation studied by temperature-tuned FTIR spectroscopy.
Biopolymers 73: 463–469.
El-Agnaf,O.M.A., Sheridan, J.M., Sidera, C., Siligardi,G.,Hussain,R.,Haris,
P.I., and Austen, B.M. 2001. Effect of the disulfide bridge and the C-
terminal extension on the oligomerization of the amyloid peptide ABri
implicated in familial British dementia. Biochemistry 40: 3449–3457.
El-Agnaf, O.M.A., Gibson, G., Lee, M., Wright, A., and Austen, B.M.
2004. Properties of neurotoxic peptides related to the Bri gene. Protein
Pept. Lett. 11: 202–212.
Ferguson, N., Berriman, J., Petrovich, M., Sharpe, T.D., Finch, J.T., and
Fersht, A.R. 2003. Rapid amyloid fibril formation from the fast-fold-
ing WW domain FBP28. Proc. Natl. Acad. Sci. 100: 9814–9819.
Fernandez Escamilla, A.M., Rousseau, F., Schymkowitz, J., and Serrano, L.
2004. Prediction of sequence-dependent and mutational effects on the
aggregation of peptides and proteins.Nat. Biotech. 22: 1302–1306.
Ferrara, P., Apostolakis, J., andCaflisch, A. 2002. Evaluation of a fast implicit
solvent model for molecular dynamics simulations. Proteins 46: 24–33.
Fersht, A.R. 1999. Structure and mechanism in protein science. Freeman
and Co., New York.
Gasteiger, E., Gattiker, A., Hoogland, C., Ivanyi, I., Appel, R.D., and
Bairoch, A. 2003. Expasy: The proteomics server for in depth protein
knowledge and analysis. Nucleic Acids Res. 31: 3784–3788.
Gazit, E. 2002. A possible role for p-stacking in the self-assembly of
amyloid fibrils. FASEB J. 16: 77–83.
Gordon, D.J., Balbach, J.J., Tycko, R., andMeredith, S.C. 2004. Increasing
the amphiphilicity of an amyloidogenic peptide changes the b-sheet
structure in the fibrils from antiparallel to parallel. Biophys. J. 86:
428–434.
Gsponer, J., Habertuer, U., and Caflisch, A. 2003. The role of side-chain
interactions in the early steps of aggregation: Molecular dynamics
simulations of an amyloid-forming peptide from the yeast prion
Sup35. Proc. Natl. Acad. Sci. 100: 5154–5159.
Haggqvist, B., Naeslund, J., Sletten, K., Westermark, G.T., Mucchiano,
G., Tjernberg, L.O., Nordstedt, C., Engstroem, U., and Westermark, P.
1999. Medin: An integral fragment of aortic smooth muscle cell-pro-
duced lactadherin forms the most common human amyloid. Proc. Natl.
Acad. Sci. 96: 8669–8674.
Hill, A.F., Joiner, S., Linehan, J., Desbruslais, M., Lantos, P.L., and
Collinge, J. 2000. Species-barrier-independent prion replicates in appar-
ently resistant species. Proc. Natl. Acad. Sci. 97: 10248–10253.
Horwich, A.L. and Weissman, J.S. 1997. Deadly conformations-protein
misfolding disease. Cell 89: 499–510.
Hwang, W., Zhang, S., Kamm, R.D., and Karplus, M. 2004. Kinetic
control of dimer structure formation in amyloid fibrillogenesis. Proc.
Natl. Acad. Sci. 101: 12916–12921.
Jaroniec, C.P., MacPhee, C.E., Astrof, N.S., Dobson, C.M., and Griffin,
R.G. 2002. Molecular conformation of a peptide fragment of transthy-
retin in an amyloid fibril. Proc. Natl. Acad. Sci. 99: 16748–16753.
Jarrett, J., Berger, E.P., and Lansbury Jr., P.T. 1993. The carboxyl termi-
nus of the b amyloid protein critical for the seeding of amyloid forma-
tion: Implications for the pathogenesis of Alzheimer’s disease.
Biochemistry 32: 4693–4697.
Jenkins, J. and Pickersgill, R. 2001. The architecture of parallel b-helices
and related folds. Prog. Biophys. Mol. Biol. 77: 111–115.
Jimenez, J.L., Nettleton, E.J., Bouchard, M., Robinson, C.V., Dobson,
C.M., and Saibil, H.R. 2002. The protofilament structure of insulin
amyloid fibrils. Proc. Natl. Acad. Sci. 99: 9196–9201.
Jones, S., Manning, J., Kad, N.M., and Radford, S.E. 2003. Amyloid-
forming peptides from b2 microglobulin—Insights into the mechanism
of fibril formation in vitro. J. Mol. Biol. 325: 249–257.
Kangas, H., Paunio, T., Kalkkinen, N., Jalanko, A., and Peltonen, L. 1996.
In vitro expression analysis shows that the secretory form of Gelsolin is
www.proteinscience.org 2733
Prediction of b-aggregation rate and segments
60
the sole source of amyloid in Gelsolin-related amyloidosis. Hum. Mol.
Genet. 5: 1237–1244.
Kayed, R., Bernhagen, J., Greenfield, N., Sweimeh, K., Brummer, H.,
Voelter, W., and Kapurniotu, A. 1999a. Conformational transitions
of islet amyloid polypeptide (IAPP) in amyloid formation in vitro. J.
Mol. Biol. 287: 781–796.
———. 1999b. Partial molar volume, surface area, and hydration changes
for equilibrium unfolding and formation of aggregation transition
state: High-pressure and cosolute studies on recombinant human
IFN-g. J. Mol. Biol. 287: 781–796.
Kelly, J. 1998. The alternative conformations of amyloidogenic proteins
and their multi-step assembly pathways. Curr. Opin. Struct. Biol. 8:
101–106.
King, C.Y., Tittmann, P., Gross, H., Gebert, R., Aebi, M., and Wuethrich,
K. 1997. Prion-inducing domain 2–114 of yeast Sup35 protein trans-
forms in vitro into amyloid-like filaments. Proc. Natl. Acad. Sci. 94:
6618–6622.
Konno, T., Murata, K., and Nagayama, K. 1999. Amyloid-like aggregates
of a plant protein: A case of sweet tasting protein, monellin. FEBS Lett.
454: 122–126.
Kozin, S.A., Bertho, G., Mazur, A.K., Rabesona, H., Girault, J.P.,
Haerlthe´, T., Takahashi, M., Debey, P., and Hui Bon Hoa, G. 2001.
Sheep prion protein synthetic peptide spanning helix 1 and b-strand 2
residues 142–166 shows b-hairpin structure in solution. J. Biol. Chem.
49: 46364–46370.
Kusumoto, Y., Lomakin, A., Teplow, D.B., and Benedek, G.B. 1998.
Temperature dependence of amyloid b-protein fibrillization. Proc.
Natl. Acad. Sci. 95: 12277–12282.
Linding, R., Schymkowitz, J., Rousseau, J., Diella, F., and Serrano, L.
2004. A comparative study of the relationship between protein struc-
ture and b-aggregation in globular and intrinsically disordered pro-
teins. J. Mol. Biol. 342: 345–353.
Litvinovich, S.V., Brew, S.A., Aota, S., Akiyama, S.K., Haudenschild, C.,
and Ingham, K.C. 1998. Formation of amyloid like fibrils by self-
association of a partially unfolded fibronectin type III module. J.
Mol. Biol. 280: 245–258.
Lomakin, A., Chung, D.S., Benedek, G.B., Kirschner, D.A., and Teplow,
D.B. 1996. On the nucleation and growth of amyloid b-protein fibrils:
Detection of nuclei and quantitation of rate constants. Proc. Natl.
Acad. Sci. 93: 1125–1129.
Lomakin, A., Teplow, D.B., Kirschner, D.A., and Benedek, G.B. 1997.
Kinetic theory of fibrillogenesis of amyloid b-protein. Proc. Natl. Acad.
Sci. 94: 7942–7947.
Makin, O.S., Atkins, E., Sikorski, P., Johansson, J., and Serpell, L.C. 2005.
Molecular basis for amyloid fibril formation and stability. Proc. Natl.
Acad. Sci. 102: 315–320.
Marcotte, E.M. and Eisenberg, D. 1999. Chicken prion tandem repeats
form a stable, protease-resistant domain. Biochemistry 38: 667–676.
Margittai, M. and Langen, R. 2004. Template-assisted filament growth by
parallel stacking of t. Proc. Natl. Acad. Sci. 101: 10279–10283.
Massi, F. and Straub, J.E. 2001. Energy landscape theory for Alzheimer’s
amyloid b-peptide fibril elongation. Proteins 42: 217–229.
Matthews, D. and Cooke, B. 2003. The potential for transmissible spongi-
form encephalopathies in non-ruminant livestock and fish. Rev. Sci.
Tech. 22: 283–296.
McGaughey, G.B., Gagne´, M., and Rappe´, A.K. 1998. p-Stacking inter-
action. J. Biol. Chem. 273: 15458–15463.
Michelitsch, M.D. and Weissman, J.S. 2000. A census of glutamine/aspar-
agine-rich regions: Implications for their conserved function and the
prediction of novel prions. Proc. Natl. Acad. Sci. 97: 11910–11915.
Munishkina, L.A., Fink, A.L., and Uversky, V.U. 2004. Conformational
prerequisites for formation of amyloid fibrils from histones. J. Mol.
Biol. 342: 1305–1324.
Nahway, N. 1989. The Merck index. Merck and Co., Inc., Whitehouse
Station, NJ.
Nguyen, J., Baldwin, M.A., Cohen, F.E., and Prusiner, S.B. 1995. Prion
protein peptides induce a-helix to b-sheet conformational transitions.
Biochemistry 34: 4186–4192.
Nichols, W.C., Dwulet, F.E., Liepnieks, J., and Benson, M.D. 1988. Vari-
ant apolipoprotein AI as a major constituent of a human hereditary
amyloid. Biochem. Biophys. Res. Commun. 156: 762–768.
Padrick, S.B. and Miranker, A.D. 2002. Islet amyloid: Phase partitioning
and secondary nucleation are central to the mechanism of fibrillogen-
esis. Biochemistry 41: 4694–4703.
Perutz, M.F. 1999. Glutamine repeats and neurodegenerative diseases:
Molecular aspects. Trends Biochem. Sci. 24: 58–64.
Perutz, M.F., Johnson, T., Suzuki, M., and Finch, J.T. 1994. Glutamine
repeats as polar zippers: Their possible role in inherited neurodegen-
erative diseases. Proc. Natl. Acad. Sci. 91: 5355–5358.
Porat, Y., Stepensky, A., Ding, F.X., Naider, F., and Gazit, E. 2003.
Completely different amyloidogenic potential of nearly identical pep-
tide fragments. Biopolymers 69: 161–163.
Prusiner, S.B. 1988. Prions. Proc. Natl. Acad. Sci. 95: 13363–13383.
Rochet, J.C. and Lansbury Jr., P.T. 2000. Amyloid fibrillogenesis: Themes
and variations. Curr. Opin. Struct. Biol. 10: 60–68.
Scherzinger, E., Lurz, R., Turmaine, M., Mangiarini, L., Hollenback,
B., Hasenbank, R., Bates, G.P., Davies, S.W., Lehrack, H., and
Wanker, E. 1997. Huntingtin-encoded polyglutamine expansions
form amyloid-like protein aggregates in vitro and in vivo. Cell 90:
549–558.
Soto, C. and Castilla, J. 2004. The controversial protein-only hypothesis of
prion propagation. Nat. Med. 10: S63–S67.
Stefani, M. and Dobson, C.M. 2003. Protein aggregation and aggregate
toxicity: New insights into protein folding, misfolding diseases and
biological evolution. J. Mol. Med. 81: 678–699.
Tanaka, M., Morishima, I., Akagi, T., Hashikawa, T., and Nukina, N.
2001. Intra and intermolecular b-pleated sheet formation in glutamine-
repeat inserted myoglobin as a model for polyglutamine diseases. J.
Biol. Chem. 276: 45470–45475.
Tartaglia, G.G., Cavalli, A., Pellarin, R., and Caflisch, A. 2004. The role of
aromaticity, exposed surface, and dipole moment in determining pro-
tein aggregation rates. Protein Sci. 13: 1939–1941.
Tartaglia, G.G., Pellarin, R., Cavalli, A., and Caflisch, A. 2005. Organism
complexity anti-correlates with proteomic b-aggregation propensity.
Protein Sci. (this issue).
Tenidis, K., Waldner, M., Bernhagen, J., Fischle, W., Bermann, M., Weber,
M., Merkle, M., Voelter, W., Brunner, H., and Kapurniotu, A. 2000.
Identification of a penta- and hexapeptide of Islet amyloid polypeptide
IAPPwith amyloidogenic and cytotoxicproperties.J.Mol. Biol. 295:1055–
1071.
Thompson, J.D., Higgins, D.G., and Gibson, T.J. 1994. Clustal W:
Improving the sensitivity of progressive multiple sequence alignment
through sequence weighting, positions-specific gap penalties and weight
matrix choice. Nucleic Acids Res. 22: 4673–4680.
Tjernberg, L., Hosia, W., Bark, N., Thyberg, J., and Johansson, J.
2002. Charge attraction and b-propensity are necessary for amyloid
fibril formation from tetrapeptides. J. Biol. Chem. 277: 43243–
43246.
Torok, M., Milton, S., Kayed, R., Wu, P., Intire, T.M., Glabe, C., and
Langen, R. 2002. Structural and dynamic features of Alzheimer Ab
peptide in amyloid fibrils studied by site-directed spin labeling. J. Biol.
Chem. 277: 40810–40815.
Ueda, K., Fukushima, H., Masliah, E., Xia, Y., Iwai, A., Yoshimoto,
M., Otero, D.A., Kondo, J., Ihara, Y., and Saitoh, T. 1993. Molec-
ular cloning of cDNA encoding an unrecognized component of
amyloid in Alzheimer disease. Proc. Natl. Acad. Sci. 90: 11282–
11286.
Vanik, D.L., Surewicz, K.A., and Surewicz, W.K. 2004. Molecular basis of
barriers for intraspecies transmissibility of mammalian prions. Mol.
Cell 14: 139–145.
von Bergen, M., Friedhoff, P., Biernat, J., Heberle, J., Mandelkow, E.M.,
and Mandelkow, E. 2000. Assembly of t protein into Alzheimer paired
helical filaments depends on a local sequence motif (306VQIVYK311)
forming b-structure. Proc. Natl. Acad. Sci. 97: 5129–5134.
Weidemann, A., Konig, G., Bunke, D., Fisher, P., Salbaum, J.M., Masters,
C.L., and Beyreuther, K. 1989. Identification, biogenesis and localization
of precursors of Alzheimer’s disease A4 amyloid protein.Cell 57: 115–126.
Westermark, P., Wernstedt, C., Wilander, E., Hayden, D.W., O’Brien,
T.D., and Johnson, K.H. 1987. Amyloid fibrils in human insulinoma
and islets of Langerhans of the diabetic cat are derived from a neuro-
peptide-like protein also present in normal islet cells. Proc. Natl. Acad.
Sci. 84: 3881–3885.
Westermark, G.T., Engstrom, U., and Westermark, P. 1992. The N-termi-
nal segment of protein AA determines its fibrillogenic propensity.
Biochem. Biophys. Res. Commun. 182: 27–32.
Williams, A.D., Portelius, E., Kheterpal, I., Guo, J.T., Cook, K.D., Xu, Y.,
and Wetzel, R. 2004. Mapping Ab amyloid fibril secondary structure
using scanning proline mutagenesis. J. Mol. Biol. 335: 833–842.
Zoete, V., Michielin, O., and Karplus, M. 2003. Protein-ligand binding free
energy estimation using molecular mechanics and continuum electro-
statics. Application to HIV-1 protease inhibitors. J. Comput. Aided
Mol. Des. 17: 861–880.
2734 Protein Science, vol. 14
Tartaglia et al.
61
Chapter 5
Organism Complexity
Anticorrelates with
Proteomic β- Aggregation
Propensity
Protein Science (2005) 14, 2735-2740
62
FOR THE RECORD
Organism complexity anti-correlates with proteomic
b-aggregation propensity
GIAN GAETANO TARTAGLIA,1 RICCARDO PELLARIN,1 ANDREA CAVALLI,
AND AMEDEO CAFLISCH
Department of Biochemistry, University of Zu¨rich, CH-8057 Zu¨rich, Switzerland
(RECEIVED March 23, 2005; FINAL REVISION June 23, 2005; ACCEPTED June 24, 2005)
Abstract
We introduce a novel approach to estimate differences in the b-aggregation potential of eukaryotic
proteomes. The approach is based on a statistical analysis of the b-aggregation propensity of poly-
peptide segments, which is calculated by an equation derived from first principles using the physico-
chemical properties of the natural amino acids. Our analysis reveals a significant decreasing trend of
the overall b-aggregation tendency with increasing organism complexity and longevity. A comparison
with randomized proteomes shows that natural proteomes have a higher degree of polarization in
both low and high b-aggregation prone sequences. The former originates from the requirement of
intrinsically disordered proteins, whereas the latter originates from the necessity of proteins with a
stable folded structure.
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Even proteins not implicated in amyloid diseases have
been shown to form fibrils in vitro under denaturing con-
ditions, indicating that fibrillogenesis is a common feature
of polypeptide chains, which can form intermolecular
backbone–backbone hydrogen bonds (Chiti et al. 1999,
2003) and favorable side-chain interactions (Azriel and
Gazit 2001; Gsponer et al. 2003; Makin et al. 2005).
Although in lower eukaryotes amyloid fibrils could repre-
sent an inheritable phenotype related to specific cellular
functions (Osherovich and Weissman 2002; Osherovich et
al. 2004; Si et al. 2003b), the cytotoxicity of prefibrillar
aggregates (Bucciantini et al. 2002) and their association
with diseases such as Alzheimer’s, Parkinson’s, Hunting-
ton’s, prion disease, cystic fibrosis, and type II diabetes
(Kelly 1998; Rochet and Lansbury 2000) suggest that
amyloid aggregates are generally dangerous for higher
eukaryotes (Dobson 1999; Stefani and Dobson 2003).
We have previously developed an equation to predict
the propensity for ordered aggregation, which solely
requires the polypeptide sequence as input (Tartaglia et
al. 2004, 2005). Our model is based on the physicochem-
ical properties of the residues and takes into account
both amino acid composition and positional informa-
tion. The aggregation propensity pil of an l-residue seg-
ment starting at position i in the sequence is evaluated as
il ¼ il il ð1Þ
The factor Fil contains exponential functions and is
position-dependent
il ¼ e
AilþBilþCil ð2Þ
where Ail, Bil, and Cil are functionals related to the aro-
maticity, b-propensity, and charge, respectively. The fac-
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tor il depends almost exclusively on the amino acid com-
position
il ¼
Yiþl1
j¼i
Saj
S^a
"" þ
S
p
j
S^p
"#
 
S^t
Stj
^
j
" #1=l
ð3Þ
where Sai , S
p
i , S
t
i, and si—weighted by their average over
the 20 standard amino acids (hatted values)—are the side-
chain apolar, polar, total water-accessible surface area,
and solubility, respectively. The functionals y"" and y"#
include positional effects and reflect the parallel or anti-
parallel tendency to aggregate if the majority of residues is
apolar or polar, respectively. Details of the method are
presented in the preceding paper (Tartaglia et al. 2005).
In the present work, we analyze complete proteomes
of several eukaryotes to identify changes of b-aggrega-
tion propensity through organisms of different complex-
ity. The 32,869 entries belonging to the human proteome
database (Supplemental Material, Table 1) were decom-
posed in stretches of different sizes (5, 50, and 150 resi-
dues) to compute the b-aggregation propensity with
Equation 1 and build the normalized histogram of b-
aggregation propensity distribution, APD (Fig. 1A). For
each stretch size, the distribution is found to be nonsym-
metric with respect to the average and skewed to the left,
indicating that there are more stretches with low b-
aggregation propensity (left tail of APD) than with
high propensity (right tail). As pointed out in our pre-
vious study, short stretches are preferable to long
stretches for the analysis of b-aggregation propensity
because the latter contain folding features that deterio-
rate the signal-to-noise ratio (Tartaglia et al. 2005).
Figure 1. (A) (Inset) Distribution of the number of human polypeptide sequences as a function of b-aggregation propensity
(APD) at three different window sizes. (Main plot) APD differences with respect to H. sapiens for complete proteomes of M.
musculus, D. melanogaster, C. elegans, S. cerevisiae, and P. tetraurelia (window size of five residues). Life spans of organisms are
reported in parentheses. (B) Unrooted tree diagram derived from the APD deviation (Equation 4). The deviation is computed
from P. tetraurelia as a reference and magnified by a factor of 1000. The arrow indicates that lower eukaryotes have more high-
propensity and fewer low-propensity stretches. This diagram is built using Phylodraw with the Fitch and Margoliash (1967)
clustering algorithm. Data labeled with * belong to incomplete proteomes. (Phylodraw is available at http://pearl.cs.pusan.ac.kr/
phylodraw/.) (C) Normalized histogram of the number of proteins as a function of the content of residues enriched in low-
propensity and high-propensity stretches. Global contours are shown for all proteomes by solid lines. Isofrequency regions are
shown for the human proteome, where red color indicates the most populated area, while blue fading color indicates the least-
populated areas. (D) Same as C for shuffled proteomes.
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Hence, a window size of five residues was used to ana-
lyze complete proteomes of Homo sapiens, Mus muscu-
lus, Drosophila melanogaster, Caenorhabditis elegans,
Saccharomyces cerevisiae, and Paramecium tetraurelia
(Supplemental Material, Table 1). Nonhuman eukary-
otes show a larger amount of high-propensity stretches
and a smaller amount of low-propensity stretches com-
pared with H. sapiens (Fig. 1A). Moreover, a clear trend
is found with the increasing complexity of the organisms
and their lifetime. To quantify this trend it is useful to
introduce the APD deviation between two proteomes,
x and y
dxy ¼
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
1
N
XN
i¼1
ðAPDxðiÞ  APDyðiÞÞ
2
vuut ð4Þ
where the b-aggregation propensity p is calculated by
Equation 1 (Tartaglia et al. 2005) and i runs over the
total number of bins N (N=100) in the APD histo-
gram. With the addition of the proteomes of Danio
rerio, Xenopus laevis, and Gallus gallus, the APD devia-
tion was used to build the tree diagram of Figure 1B.
Except for the inversion between the amphibious X.
laevis and the fish D. rerio (whose proteomes are not
complete), the tree of Figure 1B is similar to the phylo-
genetic tree of cytochrome c (Dayhoff et al. 1972). Thus,
the deviation calculated from P. tetraurelia, dxP, is an
observable able to rank proteomes of organisms of
increasing complexity. It is interesting to compare the
amino acid frequencies in APD tails—defined for a
subtended area of 0.05 in the histogram of Figure
1A—with amino acid frequencies in entire proteomes
(Table 1). This analysis reveals that for all proteomes
stretches with low b-aggregation propensity are rich in
A, G, H, K, P and R, whereas high-propensity stretches
in C, F, I, L, N, Q, V, and Y. Figure 1C is a two-
dimensional histogram that shows the number of pro-
teins as a function of the content of residues enriched in
low-propensity stretches and the content of residues
predominant in high-propensity stretches. By increasing
the organism complexity, the number of proteins with
low-propensity residues increases, while the number of
proteins with high-propensity residues decreases. A com-
parison with randomized proteomes is useful to further
investigate the significance of such trends. Randomized
proteomes were generated by shuffling amino acids
within complete proteomes and keeping unchanged the
global amino acid composition, number, and length of
proteins. We stress that the b-aggregation propensity of
five-residue stretches cannot differentiate natural and
shuffled proteomes, because short segments describe
mainly effects of the amino acid composition. Yet, differ-
ences between natural and shuffled proteomes are
enhanced when residues belonging to low-/high-propen-
sity stretches are used for the analysis of entire proteins.
Comparing Figure 1, C and D, it is evident that shuffled
proteomes are less spread. In other words, natural pro-
teomes reveal a sensible increase of sequences with
residues predominant in low-propensity stretches as
well as residues enriched in high-propensity stretches.
While the amino acid global composition of proteomes
is almost identical in higher eukaryotes, the content of
low-propensity stretches increases significantly, indicat-
ing a clear change of protein features from proteome to
proteome.
It has recently been shown that natively unfolded
proteins (or intrinsically disordered proteins, IDPs)
are implicated in cellular regulation, signaling, and
assembly/disassembly of macromolecular complexes
(Dunker et al. 2002; Ward et al. 2004; Oldfield et al.
2005). The absence of a fixed structure suggests func-
tional implications, which are required in complex
organisms (Koonin et al. 2002). Interestingly, a larger
diffusion of IDPs is found in higher eukaryotes than in
lower eukaryotes and prokaryotes (Dunker et al. 2002;
Liu et al. 2002; Linding et al. 2004). Using data from X-
ray crystallography, nuclear magnetic resonance, and
circular dichroism, Williams et al. (2001) found a high
percentage of P, R, K, G, A, Q, S, and E in nonfolded
segments of proteins, and F, Y, C, L, V, N, and W in
folded segments. Except for Q, S, and E, Williams’
finding is in agreement with our tail composition anal-
ysis (Table 1), indicating that residues enriched in
aggregating stretches promote both folding and b-
aggregation, whereas residues predominant in stretches
with low b-aggregation propensity are also enriched in
IDPs.
To better understand the relationship between b-
aggregation propensity and protein structure, we ana-
lyzed the APDs of polypeptide segments that assume a
regular secondary structure, as well as IDPs (Supple-
mental Material, Table 1). As shown in Figure 2A,
strands have more b-aggregation potential than helices,
Table 1. Amino acid frequencies in left or right APD tails
of H. sapiens divided by their corresponding frequency
in the whole proteome
A C D E F G H I K L
Left/total 1.1 0.2 0.4 0.5 0.4 1.3 1.6 0.5 2.1 0.5
Right/total 0.7 2.4 0.8 0.7 2.7 0.6 0.5 1.6 0.3 1.8
M N P Q R S T V W Y
Left/total 0.4 0.2 3.3 0.3 2.8 0.6 0.5 0.7 0.4 0.1
Right/total 0.8 1.5 0.2 1.2 0.2 0.7 0.8 1.2 0.8 2.7
Values exceeding 1.0 are shown in bold. Similar frequencies were found
for all the proteomes.
www.proteinscience.org 2737
The b-aggregation propensity of proteomes
65
and IDPs are the least prone to aggregate, in agreement
with Linding’s analysis (Linding et al. 2004). Moreover,
from lower to higher eukaryotes the APD deviation with
respect to IDP decreases, while the APD deviation from
strands increases (Fig. 2B,C). The APD deviation of
helices does not follow a monotonic trend and slowly
increases from S. cerevisiae toH. sapiens. Compared with
strands, helices display a lower amount of aggregation
stretches, but it has to be mentioned that the transition
helix-strand generates amyloidogenesis in some proteins
(Selkoe 1996; Prusiner 1997).
To quantify interspecies shifts of amino acid composi-
tions in the APD tails, we fitted the amino acid frequen-
cies as a linear function of the APD deviation from P.
tetraurelia, dxP (see Equation 4)
f ax ¼ shift
a dxP þ cst
a ð5Þ
where fax is the frequency of the amino acid a in the
proteome x, shifta is the slope of the fit, and csta is the
intercept. The sign ‘‘+’’ or ‘‘’’ of the shifta was inter-
preted as a measure for the depletion or the enrichment
of the amino acid a from P. tetraurelia to H. sapiens.
Shifts obtained from high-confidence fits (Pearson’s
correlation >0.80; Supplemental Material, Table 2)
are
 Right tails, i.e., high propensity: Decrease of Q, N, Y,
and K and increase of L, V, A, W, R, H, G, and P.
 Left tails, i.e., low propensity: Decrease of K, I, F, and
N and increase of P, A, G, R, S, and E.
Interestingly, the decrease of Q, N, and Y in the right
tails was already observed in higher eukaryote prion
homologs of the yeast Sup35 prion protein (Balbirnie
et al. 2001; Si et al. 2003a; Theis et al. 2003) and suggests
that the trend does not affect only a specific family of
proteins. In addition, we speculate that the increase of L,
V, A, and W in the right tail is a consequence of the
optimization of the ‘‘hydrophobic core’’ to stabilize the
native state (Kellis et al. 1989; Richards and Lim 1993;
Dill et al. 1995; Stefani and Dobson 2003).
The functional role of aggregation phenotypes in
multicellular eukaryotes is still a matter of debate.
Recently, it has been observed that the neuronal pro-
tein CPEB of Aplysia californica behaves like a prion
switch that regulates long-term synaptic changes asso-
Figure 2. (A) APDs of five-residue stretches belonging to intrinsically disordered proteins (IDPs) or regular secondary structure
elements within folded proteins and IDPs. (B) Deviation between the APD of entire proteomes and the APD of segments
belonging to regular secondary structure or IDPs as a function of the organism complexity. The organism complexity is
measured by the APD deviation from P. tetraurelia, dxP. Solid lines are drawn solely to guide the eye. (C) From lower to higher
eukaryotes, the decrease of b-aggregation propensity is related to the increase of intrinsically disordered proteins.
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ciated with memory storage (Si et al. 2003a,b). The switch
mechanism involves the aggregation of the CPEB
N terminus, rich in Q- and N- repeats that are missing
in mammalian isoforms of CPEB (Theis et al. 2003).
Motivated by these observations, we analyzed the data
set of proteins expressed in neurons (Supplemental Mate-
rial , Table 1). For a given proteome, the neuronal APD
perfectly overlaps with the APD of the total proteome
(data not shown), indicating that neuronal proteins are a
descriptive subset of the total proteome and do not follow
any specific trend. We thus cannot draw conclusions on
particular links between memory mechanisms and aggre-
gation phenotypes.
It has been shown that the frequency of N and Q
repeats does not represent an observable able to describe
amyloidogenic trends of proteomes (Michelitsch and
Weissman 2000; Osherovich and Weissman 2002). Our
findings indicate that to quantify aggregation trends, it
is crucial to use an observable, such as the b-aggre-
gation propensity, which accounts for the aggregation
contribution of all amino acids including positional
information.
In conclusion, we have introduced a novel approach
to compare proteomes, which is based on the statistical
analysis of ordered-aggregation propensity. From P.
tetraurelia to H. sapiens, we have shown that proteomes
of higher and more long-lived eukaryotes contain fewer
sequences with high b-aggregation propensity and are
accrued in proteins with low b-aggregation propensity.
We also observed that, compared with random pro-
teomes, natural proteomes are enriched in proteins
with low b-aggregation potential, as well as proteins
with high b-aggregation potential. Such polarization is
a consequence of the dual evolutive requirement of IDPs
with low b-aggregation propensity, as well as proteins
with a stable fold, which comes at the cost of higher b-
aggregation propensity. In the future, we plan to use
gene ontology annotations of proteins with high pre-
dicted b-aggregation propensity to obtain insights into
the specific role of some of the amyloidogenic proteins of
unknown function.
Electronic supplemental material
This section contains two tables: Table 1 contains information
for databases used in the article (origin of data sets, number of
entries of the databases, and number of stretches used in our
analysis); Table 2 contains fitting parameters for the amino
acid shifts (see Equation 5).
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Chapter 6
Conclusions
The mechanisms by which peptides and proteins form ordered aggregates
are not well understood. In this study we focused on the physicochemi-
cal properties of amino acids that favour β-aggregation and suggested two
parameter-free formulas to predict the aggregation rates. An essential ele-
ment in the derivation of the models was the analysis of β-aggregating pep-
tide sequences designed by genetic algorithm optimization in sequence space
and molecular dynamics sampling of conformation space. The high correla-
tions found between predicted and measured rates indicate that our models
are able to describe in vitro experiments with high accuracy. Moreover, we
were able to build the amyloid spectrum of a protein, identifying those seg-
ments which are involved in the β-aggregation. We found that mammalian
and non-mammalian prion proteins show different amyloid-spectra, provid-
ing insights into the species barrier for the transmission of the prion disease.
More specifically, we predicted a high amyloidogenic region corresponding
to the segment SNQNN of the human prion which is absent in the chicken
and turtle. At this stage, in vitro experiments represent the most important
step to futher investigate the properties of amyloidogenic regions identified
with our method.
Although in lower eukaryotes amyoloid fibrils could represent an inheritable
phenotype related to specific cellular functions (as in the case of the neu-
ronal protein CPEB of Aplysia Californica), the cytotoxicity of prefibrillar
aggregates and their association with disease such as Alzheimer’s, Parkin-
son’s, Huntigton’s, and prion disease, suggests that amyloid aggregates
are generally dangerous for higher eukaryotes. We introduced a novel ap-
proach to compare proteomes using the statistical analysis of β-aggregation
propensity. From P. tetraurelia to H. sapiens, we have shown that pro-
teomes of higher and more long-lived eukaryotes contain fewer sequences
69
with high β-aggregation propensity and are accumulated in proteins with
low β-aggregation propensity. We plan to use gene ontology annotations of
proteins to obtain insights on the specific role of amyloidogenic proteins of
unknown function. Disordered regions of proteins will be further investi-
gated as determinant factors in preventing protein aggregation.
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